Method for replicating an array of nucleic acid probes

ABSTRACT

The invention relates to the replication of probe arrays and methods for replicating arrays of probes which are useful for the large scale manufacture of diagnostic aids used to screen biological samples for specific target sequences. Arrays created using PCR technology may comprise probes with 5&#39;- and/or 3&#39;-overhangs.

RIGHTS IN THE INVENTION

This invention was made with support from the Department of Energy undergrant number PO4591610 and the United States government has certainrights in this invention.

REFERENCE TO RELATED APPLICATIONS

This is a continuation-in-part of U.S. patent application Ser. No.07/972,012 filed Nov. 6, 1992 now U.S. Pat. No. 5,503,980.

BACKGROUND OF THE INVENTION

1. Field of the Invention

This invention relates to methods for sequencing nucleic acids bypositional hybridization and to procedures combining these methods withmore conventional sequencing techniques and with other molecular biologytechniques including techniques utilized in PCR (polymerase chainreaction) technology. Useful applications include the creation of probesand arrays of probes for detecting, identifying, purifying andsequencing target nucleic acids in biological samples. The invention isalso directed to novel methods for the replication of probe arrays, tothe replicated arrays, to diagnostic aids comprising nucleic acid probesand arrays useful for screening biological samples for target nucleicacids and nucleic acid variations.

2. Description of the Background

Since the recognition of nucleic acid as the carrier of the geneticcode, a great deal of interest has centered around determining thesequence of that code in the many forms which it is found. Two landmarkstudies made the process of nucleic acid sequencing, at least with DNA,a common and relatively rapid procedure practiced in most laboratories.The first describes a process whereby terminally labeled DNA moleculesare chemically cleaved at single base repetitions (A. M. Maxam and W.Gilbert, Proc. Natl. Acad. Sci. USA 74:560-564, 1977). Each baseposition in the nucleic acid sequence is then determined from themolecular weights of fragments produced by partial cleavages. Individualreactions were devised to cleave preferentially at guanine, at adenine,at cytosine and thymine, and at cytosine alone. When the products ofthese four reactions are resolved by molecular weight, using, forexample, polyacrylamide gel electrophoresis, DNA sequences can be readfrom the pattern of fragments on the resolved gel.

The second study describes a procedure whereby DNA is sequenced using avariation of the plus-minus method (F. Sanger et al., Proc. Natl. Acad.Sci. USA 74:5463-67, 1977). This procedure takes advantage of the chainterminating ability of dideoxynucleoside triphosphates (ddNTPs) and theability of DNA polymerase to incorporate ddNTP with nearly equalfidelity as the natural substrate of DNA polymerase, deoxynucleosidestriphosphates (dNTPs). A primer, usually an oligonucleotide, and atemplate DNA are incubated together in the presence of a usefulconcentration of all four dNTPs plus a limited amount of a single ddNTP.The DNA polymerase occasionally incorporates a dideoxynucleotide whichterminates chain extension. Because the dideoxynucleotide has no3'-hydroxyl, the initiation point for the polymerase enzyme is lost.Polymerization produces a mixture of fragments of varied sizes, allhaving identical 3' termini. Fractionation of the mixture by, forexample, polyacrylamide gel electrophoresis, produces a pattern whichindicates the presence and position of each base in the nucleic acid.Reactions with each of the four ddNTPs allows one of ordinary skill toread an entire nucleic acid sequence from a resolved gel.

Despite their advantages, these procedures are cumbersome andimpractical when one wishes to obtain megabases of sequence information.Further, these procedures are, for all practical purposes, limited tosequencing DNA. Although variations have developed, it is still notpossible using either process to obtain sequence information directlyfrom any other form of nucleic acid.

A new method of sequencing has been developed which overcomes some ofthe problems associated with current methodologies wherein sequenceinformation is obtained in multiple discrete packages. Instead of havinga particular nucleic acid sequenced one base at a time, groups ofcontiguous bases are determined simultaneously by hybridization. Thereare many advantages including increased speed, reduced expense andgreater accuracy.

Two general approaches of sequencing by hybridization have beensuggested. Their practicality has been demonstrated in pilot studies. Inone format, a complete set of 4^(n) nucleotides of length n isimmobilized as an ordered array on a solid support and an unknown DNAsequence is hybridized to this array (K. R. Khrapko et al., J. DNASequencing and Mapping 1:375-88, 1991). The resulting hybridizationpattern provides all n-tuple words in the sequence. This is sufficientto determine short sequences except for simple tandem repeats.

In the second format, an array of immobilized samples is hybridized withone short oligonucleotide at a time (Z. Strezoska et al., Proc. Natl.Acad. Sci. USA 88:10,089-93, 1991). When repeated 4^(n) times for eacholigonucleotide of length n, much of the sequence of all the immobilizedsamples would be determined. In both approaches, the intrinsic power ofthe method is that many sequenced regions are determined in parallel. Inactual practice the array size is about 10⁴ to 10⁵.

Another powerful aspect of the method is that information obtained isquite redundant, especially as the size of the nucleic acid probe grows.Mathematical simulations have shown that the method is quite resistantto experimental errors and that far fewer than all probes are necessaryto determine reliable sequence data (P. A. Pevzner et al., J. Biomol.Struc. & Dyn. 9:399-410, 1991; W. Bains, Genomics 11:295-301, 1991).

In spite of an overall optimistic outlook, there are still a number ofpotentially severe drawbacks to actual implementation of sequencing byhybridization. First and foremost among these is that 4^(n) rapidlybecomes quite a large number if chemical synthesis of all of theoligonucleotide probes is actually contemplated. Various schemes ofautomating this synthesis and compressing the products into a smallscale array, a sequencing chip, have been proposed.

A second drawback is the poor level of discrimination between acorrectly hybridized, perfectly matched duplexes, and an end mismatch.In part, these drawbacks have been addressed at least to a small degreeby the method of continuous stacking hybridization as reported by aKhrapko et al. (FEBS Lett. 256:118-22, 1989). Continuous stackinghybridization is based upon the observation that when a single-strandedoligonucleotide is hybridized adjacent to a double-strandedoligonucleotide, the two duplexes are mutually stabilized as if they arepositioned side-to-side due to a stacking contact between them. Thestability of the interaction decreases significantly as stacking isdisrupted by nucleotide displacement, gap, or terminal mismatch.Internal mismatches are presumably ignorable because their thermodynamicstability is so much less than perfect matches. Although promising, arelated problem arises which is the inability to distinguish betweenweak, but correct duplex formation, and simple background such asnon-specific adsorption of probes to the underlying support matrix.

A third drawback is that detection is monochromatic. Separate sequentialpositive and negative controls must be run to discriminate between acorrect hybridization match, a mis-match, and background.

A fourth drawback is that ambiguities develop in reading sequenceslonger than a few hundred base pairs on account of sequence recurrences.For example, if a sequence the same length of the probe recurs threetimes in the target, the sequence position cannot be uniquelydetermined. The locations of these sequence ambiguities are calledbranch points.

A fifth drawback is the effect of secondary structures in the targetnucleic acid. This could lead to blocks of sequences that are unreadableif the secondary structure is more stable than occurs on thecomplimentary strand.

A final drawback is the possibility that certain probes will haveanomalous behavior and for one reason or another, be recalcitrant tohybridization under whatever standard sets of conditions ultimatelyused. A simple example of this is the difficulty in finding matchingconditions for probes rich in G/C content. A more complex example couldbe sequences with a high propensity to form triple helices. The only wayto rigorously explore these possibilities is to carry out extensivehybridization studies with all possible oligonucleotides of length n,under the particular format and conditions chosen. This is clearlyimpractical if many sets of conditions are involved.

Among the early publication which appeared discussing sequencing byhybridization, E. M. Southern (PCT application no. WO 89/10977,published Nov. 16, 1989; which is hereby specifically incorporated byreference), described methods whereby unknown, or target, nucleic acidsare labeled, hybridized to a set of nucleotides of chosen length on asolid support, and the nucleotide sequence of the target determined, atleast partially, from knowledge of the sequence of the bound fragmentsand the pattern of hybridization observed. Although promising, as apractical matter, this method has numerous drawbacks. Probes areentirely single-stranded and binding stability is dependant upon thesize of the duplex. However, every additional nucleotide of the probenecessarily increases the size of the array by four fold creating adichotomy which severly restricts its plausible use. Further, there isan inability to deal with branch point ambiguities or secondarystructure of the target, and hybridization conditions will have to betailored or in some way accounted for for each binding event.

R. Drmanac et al. (U.S. Pat. No. 5,202,231; which is specificallyincorporated by reference) is directed to methods for sequencing byhybridization using sets of oligonucleotide probes with randonsequences. These probes, although useful, suffer from some of the samedrawbacks as the methodology of Southern (1989), and like Southern, failto recognize the advantages of stacking interactions.

K. R. Khrapko et al. (FEBS Lett. 256:118-22, 1989; and J. DNA Sequencingand Mapping 1:357-88, 1991) attempt to address some of these problemsusing a technique referred to as continuous stacking hybridization. Withcontinuous stacking, conceptually, the entire sequence of a targetnucleic acid can be determined. Basically, the target is hybridized toan array of probes, again single-stranded, denatured from the array, andthe dissociation kinetics of denaturation analyzed to determine thetarget sequence. Although also promising, discrimination between matchesand mis-matches (and simple background) is low, and further, ashybridization conditions are inconstant for each duplex, discriminationbecomes increasingly reduced with increasing target complexity.

SUMMARY OF THE INVENTION

The present invention overcomes the problems and disadvantagesassociated with current strategies and designs and provides new methodsfor rapidly and accurately determining the nucleotide sequence of anucleic acid by the herein described methods of positional sequencing byhybridization.

One embodiment of the invention is directed to arrays of R⁴ differentnucleic acid probes wherein each probe comprises a double-strandedportion of length D, a terminal single-stranded portion of length S, anda random nucleotide sequence within the single-stranded portion oflength R. These arrays may be bound to solid supports and are useful fordetermining the nucleotide sequence of unknown nucleic acids and for thedetection, identification and purification of target nucleic acids inbiological samples.

Another embodiment of the invention is directed to methods for creatingarrays of probes comprising the steps of synthesizing a first set ofnucleic acids each comprising a constant sequence of length C at the3'-terminus, and a random sequence of length R at the 5'-terminus,synthesizing a second set of nucleic acids each comprising a sequencecomplimentary to the constant sequence of the first nucleic acid, andhybridizing the first set with the second set to form the array.

Another embodiment of the invention is directed to methods for creatingarrays of probes comprising the steps of synthesizing a set of nucleicacids each containing a random internal sequence of length R flanked bythe cleavage sites of a restriction enzyme, synthesizing a set ofprimers each compliementary to a non-random sequence of the nucleicacid, hybridizing the two sets together to form hybrids, extending thesequence of the primer by polymerization using the nucleic acid as atemplate, and cleaving the hybrids with the restriction enzyme to forman array of probes with a double-stranded portion and a single-strandedportion and with the random sequence within the single stranded portion.

Another embodiment of the invention is directed to replicated arrays andmethods for replicating arrays of probes, preferably on a solid support,comprising the steps of synthesizing an array of nucleic acids eachcomprising a constant sequence of length C at a 3'-terminus and a randomsequence of length R at a 5'-terminus, fixing the array to a first solidsupport, synthesizing a set of nucleic acids each comprising a sequencecomplimentary to the constant region of the array, hybridizing thenucleic acids of the set with the array, enzymatically extending thenucleic acids of the set using the random sequences of the array astemplates, denaturing the set of extended nucleic acids, and fixing thedenatured nucleic acids of the set to a second solid support to createthe replicated array of probes. The replicated array may besingle-stranded or double-stranded, it may be fixed to a solid supportor free in solution, and it is useful for sequencing, detecting orsimply identifying target nucleic acids.

The array is also useful for the purification of nucleic acid from acomplex mixture for later identification and/or sequencing. Apurification array comprises sufficient numbers of probes to hybridizeand thereby effectively capture the target sequences from a complexsample. The hybridized array is washed to remove non-target nucleicacids and any other materials which may be present and the targetsequences eluted by denaturing. From the elution, purified orsemi-purified target sequences are obtained and collected. Thiscollection of target sequences can then be subjected to normalsequencing methods or sequenced by the methods described herein.

Another embodiment of the invention is directed to nucleic acid probesand methods for creating nucleic acid probes comprising the steps ofsynthesizing a plurality of single-stranded first nucleic acids and aplurality of longer single-stranded second nucleic acids wherein eacheach second nucleic acid comprises a random terminal sequence and asequence complimentary to a sequence of the first nucleic acids,hybridizing the first nucleic acids to the second to form partialduplexes having a double-stranded portion and a single-stranded portionwith the random sequence within the single-stranded portion, hybridizinga target nucleic acid to the partial duplexes, optionally ligating thehybridized target to the first nucleic acid of the partial duplexes,isolating the second nucleic acid from the ligated duplexes,synthesizing a plurality of third nucleic acids each complimentary tothe constant sequence of the second nucleic acid, and hybridizing thethird nucleic acids with the isolated second nucleic acids to create thenucleic acid probe. Alternatively, after formation of the partialduplexes, the target is ligated as before and hybridized with a set ofoligonucleotides comprising random sequences. These oligonucleotides areligated to the second nucleic acid, the second nucleic acid is isolated,another plurality of first nucleic acids are synthesized, and the firstnucleic acids are hybridized to the oligonucleotide ligated secondnucleic acids to form the probe. Ligation allows for hybridization to beperformed under a single set of hybridization conditions. Probes may befixed to a solid support and may also contain enzyme recognition siteswithin their sequences.

Another embodiment of the invention is directed to diagnostic aids andmethods utilizing probe arrays for the detection and identification oftarget nucleic acids in biological samples and to methods for using thediagnostic aids to screen biological samples. Diagnostic aids asdescribed are also useful for the purification of identified targetsand, if desired, for their sequencing. These aids comprise probes, solidsupports, labels, necessary reagents and the biological samples.

Other advantages of the invention are set forth in part in thedescription which follows, and in part, will be obvious from thisdescription, or may be learned from the practice of this invention. Theaccompanying drawings which are incorporated in and constitute a part ofthis specification, illustrate and, together with this description,serve to explain the principle of the invention.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 Energetics of stacking hybridization. Structures consist of along target and a probe of length n. The top three sample are ordinaryhybridization and the bottom three are stacking hybridization.

FIG. 2 (A) The first step of the basic scheme for positional sequencingby hybridization depicting the hybridization of target nucleic acid withprobe forming a 5' overhang of the target.

(B) The first step of the alternate scheme for positional sequencing byhybridization depicting the hybridization of target nucleic acid withprobe forming a 3' overhang of the probe.

FIG. 3 Graphic representation of the ligation step of positionalsequencing by hybridization wherein hybridization of the target nucleicacid produces (A) a 5' overhang or (B) a 3' overhang.

FIG. 4 Preparation of a random probe array.

FIG. 5 Single nucleotide extension of a probe hybridized with a targetnucleic acid using DNA polymerase and a single dideoxynucleotide.

FIG. 6 Preparation of a nested set of targets using labeled targetnucleic acids partially digested with exonuclease III.

FIG. 7 Determination of positional information using the ratio ofinternal label to terminal label.

FIG. 8 (A) Extension of one strand of the probe using a hybridizedtarget as template with a single deoxynucleotide.

(B) Hybridization of target with a fixed probe followed by ligation ofprobe to target.

FIG. 9 Four color analysis of sequence extensions of the 3' end of aprobe using three labeled nucleoside triphosphates and one unlabeledchain terminator.

FIG. 10 Extension of a nucleic acid probe by ligation of apentanucleotide 3' blocked to prevent polymerization.

FIG. 11 Preparation of a customized probe containing a 10 base pairsequence that was present in the original target nucleic acid.

FIG. 12 Graphic representation of the general procedure of positionalsequencing by hybridization.

FIG. 13 Graphical representation of the ligation efficiency ofpositional sequencing. Depicted is the relationship between the amountof label remaining over the total amounts of label in the reaction,verses NaCl concentration.

FIG. 14 A diagrammatic representation of the construction of acomplimentary array of master beads.

DESCRIPTION OF THE INVENTION

The present invention overcomes the problems and disadvantagesassociated with current strategies and designs and provides new methodsand probes, new diagnostic aids and methods for using the diagnosticaids, and new arrays and methods for creating arrays of probes todetect, identify, purify and sequence target nucleic acids. Nucleicacids of the invention include sequences of deoxyribonucleic acid (DNA)or ribonucleic acid (RNA) which may be isolated from natural sources,recombinantly produced, or artificially synthesized. Preferredembodiments of the present invention is probe synthesized usingtraditional chemical synthesis, using the more rapid polymerase chainreaction (PCR) technology, or using a combination of these two methods.

Nucleic acids of the invention further encompass polyamide nucleic acid(PNA) or any sequence of what are commonly referred to as bases joinedby a chemical backbone that have the ability to base pair or hybridizewith a complimentary chemical structure. The bases of DNA, RNA, and PNAare purines and pyrimidines linearly linked to a chemical backbone.Common chemical backbone structures are deoxyribose phosphate and ribosephosphate. Recent studies demonstrated that a number of additionalstructures may also be effective, such as the polyamide backbone of PNA(P. E. Nielsen et al., Sci. 254:1497-1500, 1991).

The purines found in both DNA and RNA are adenine and guanine, butothers known to exist are xanthine, hypoxanthine, 2- and1-diaminopurine, and other more modified bases. The pyrimidines arecytosine, which is common to both DNA and RNA, uracil foundpredominantly in RNA, and thymidine which occurs exclusively in DNA.Some of the more atypical pyrimidines include methylcytosine,hydroxymethyl-cytosine, methyluracil, hydroxymethyluracil,dihydroxypentyluracil, and other base modifications. These basesinteract in a complimentary fashion to form base-pairs, such as, forexample, guanine with cytosine and adenine with thymidine. However, thisinvention also encompasses situations in which there is nontraditionalbase pairing such as Hoogsteen base pairing which has been identified incertain tRNA molecules and postulated to exist in a triple helix.

One embodiment of the invention is directed to a method for determininga nucleotide sequence by positional hybridization comprising the stepsof (a) creating a set of nucleic acid probes wherein each probe has adouble-stranded portion, a single-stranded portion, and a randomsequence within the single-stranded portion which is determinable, (b)hybridizing a nucleic acid target which is at least partlysingle-stranded to the set of nucleic acid probes, and (c) determiningthe nucleotide sequence of the target which hybridized to thesingle-stranded portion of any probe. The set of nucleic acid probes andthe target nucleic acid may comprise DNA, RNA, PNA, or any combinationthereof, and may be derived from natural sources, recombinant sources,or be synthetically produced. Each probe of the set of nucleic acidprobes has a double-stranded portion which is preferably about 10 to 30nucleotides in length, a single-stranded portion which is preferablyabout 4 to 20 nucleotides in length, and a random sequence within thesingle-stranded portion which is preferably about 4 to 20 nucleotides inlength and more preferably about 5 nucleotides in length. A principleadvantage of this probe is in its structure. Hybridization of the targetnucleic acid is encouraged due to the favorable thermodynamic conditionsestablished by the presence of the adjacent double-strandedness of theprobe. An entire set of probes contains at least one example of everypossible random nucleotide sequence.

By way of example only, if the random portion consisted of a fournucleotide sequence (R=4) of adenine, guanine, thymine, and cystosine,the total number of possible combinations (4^(R)) would be 4⁴ or 256different nucleic acid probes. If the number of nucleotides in therandom sequence was five, the number of different probes within the setwould be 4⁵ or 1,024. This becomes a very large number indeed whenconsidering sequences of 20 nucleotides or more.

However, to determine the complete sequence of a nucleic acid target,the set of probes need not contain every possible combination ofnucleotides of the random sequence to be encompassed by the method ofthis invention. This variation of the invention is based on the theoryof degenerated probes proposed by S. C. Macevicz (International PatentApplication, US89-04741, published 1989, and herein specificallyincorporated by reference). The probes are divided into four subsets. Ineach, one of the four bases is used at a defined number of positions andall other bases except that one on the remaining positions. Probes fromthe first subset contain two elements, A and non-A (A=adenosine). For anucleic acid sequence of length k, there are 4(2^(k) -1), instead of4^(k) probes. Where k=8, a set of probes would consist of only 1020different members instead of the entire set of 65,536. The savings intime and expense would be considerable. In addition, it is also a methodof the present invention to utilize probes wherein the random nucleotidesequence contains gapped segments, or positions along the randomsequence which will base pair with any nucleotide or at least notinterfere with adjacent base pairing.

Hybridization between complimentary bases of DNA, RNA, PNA, orcombinations of DNA, RNA and PNA, occurs under a wide variety ofconditions such as variations in temperature, salt concentration,electrostatic strength, and buffer composition. Examples of theseconditions and methods for applying them are described in Nucleic AcidHybridization: A Practical Approach (B. D. Hames and S. J. Higgins,editors, IRL Press, 1985), which is herein specifically incorporated byreference. It is preferred that hybridization takes place between about0° C. and about 70° C., for periods of from about 5 minutes to hours,depending on the nature of the sequence to be hybridized and its length.For example, typical hybridization conditions for a mixture of two20-mers is to bring the mixture to 68° C. and let cool to roomtemperature (22° C.) for five minutes or at very low temperatures suchas 2° C. in 2 microliters. It is also preferred that hybridizationbetween nucleic acids be facilitated using buffers such as saline,Tris-EDTA (TE), Tris-HCl and other aqueous solutions, certain reagentsand chemicals. Preferred examples of these reagents includesingle-stranded binding proteins such as Rec A protein, T4 gene 32protein, E. coli single-stranded binding protein, and major or minornucleic acid groove binding proteins. Preferred examples of otherreagents and chemicals include divalent ions, polyvalent ions, andintercalating substances such as ethidium bromide, actinomycin D,psoralen, and angelicin.

The nucleotide sequence of the random portion of each probe isdeterminable by methods which are well-known in the art. Two methods fordetermining the sequence of the nucleic acid probe are by chemicalcleavage, as disclosed by Maxam and Gilbert (1977), and by chainextension using ddNTPs, as disclosed by Sanger et al. (1977), both ofwhich are herein specifically incorporated by reference. Alternatively,another method for determining the nucleotide sequence of a probe is toindividually synthesize each member of a probe set. The entire set wouldcomprise every possible sequence within the random portion or somesmaller portion of the set. The method of the present invention couldthen be conducted with each member of the set. Another procedure wouldbe to synthesize one or more sets of nucleic acid probes simultaneouslyon a solid support. Preferred examples of a solid support include aplastic, a ceramic, a metal, a resin, a gel, and a membrane. A morepreferred embodiment comprises a two-dimensional or three-dimensionalmatrix, such as a gel, with multiple probe binding sites, such as ahybridization chip as described by Pevzner et al. (J. Biomol. Struc. &Dyn. 9:399-410, 1991), and by Maskos and Southern (Nuc. Acids Res.20:1679-84, 1992), both of which are herein specifically incorporated byreference. Nucleic acids are bound to the solid support by covalentbinding such as by conjugation with a coupling agent, or by non-covalentbinding such as an electrostatic interaction or antibody-antigencoupling. Typical coupling agents include biotin/streptavidin,Staphylococcus aureus protein A/IgG antibody F_(c) fragment, andstreptavidin/protein A chimeras (T. Sano and C. R. Cantor,Bio/Technology 9:1378-81, 1991).

Hybridization chips can be used to construct very large probe arrayswhich are subsequently hybridized with a target nucleic acid. Analysisof the hybridization pattern of the chip provides an immediatefingerprint identification of the target nucleotide sequence. Patternscan be manually or computer analyzed, but it is clear that positionalsequencing by hybridization lends itself to computer analysis andautomation. Algorithms and software have been developed for sequencereconstruction which are applicable to the methods described herein (R.Drmanac et al., J. Biomol. Struc. & Dyn. 5:1085-1102, 1991; P. A.Pevzner, J. Biomol. Struc. & Dyn. 7:63-73, 1989, both of which areherein specifically incorporated by reference).

Preferably, target nucleic acids are labeled with a detectable label.Label may be incorporated at a 5' terminal site, a 3' terminal site, orat an internal site within the length of the nucleic acid. Preferreddetectable labels include a radioisotope, a stable isotope, an enzyme, afluorescent chemical, a luminescent chemical, a chromatic chemical, ametal, an electric charge, or a spatial structure. There are manyprocedures whereby one of ordinary skill can incorporate detectablelabel into a nucleic acid. For example, enzymes used in molecularbiology will incorporate radioisotope labeled substrate into nucleicacid. These include polymerases, kinases, and transferases. The labelingisotope is preferably, ³² P, ³⁵ S, ¹⁴ C, or ¹²⁵ I.

Label may be directly or indirectly detected using scintillation fluidor a PhosphorImager, chromatic or fluorescent labeling, or massspectrometry. Other, more advanced methods of detection includeevanescent wave detection of surface plasmon resonance of thin metalfilm labels such as gold, by, for example, the BIAcore sensor sold byPharmacia, or other suitable biosensors. Alternatively, the probe may belabeled and the target nucleic acid detected, identified and possiblysequenced from interaction with the labeled probe. For example, alabeled probe or array of probes may be fixed to a solid support. Froman analysis of the binding observed after hybridization with abiological sample containing nucleic acid, the target nucleic acid isidentified.

Another embodiment of the invention is directed to methods fordetermining a sequence of a nucleic acid comprising the steps oflabeling the nucleic acid with a first detectable label at a terminalsite, labeling the nucleic acid with a second detectable label at aninternal site, identifying the nucleotide sequences of portions of thenucleic acid, determining the relationship of the nucleotide sequenceportions to the nucleic acid by comparing the first detectable label andthe second detectable label, and determining the nucleotide sequence ofthe nucleic acid. Fragments of target nucleic acids labeled bothterminally and internally can be distinguished based on the relativeamounts of each label within respective fragments. Fragments of a targetnucleic acid terminally labeled with a first detectable label will havethe same amount of label as fragments which include the labeledterminus. However, theses fragments will have variable amounts of theinternal label directly proportional to their size and distance for theterminus. By comparing the relative amount of the first label to therelative amount of the second label in each fragment, one of ordinaryskill is able to determine the position of the fragment or the positionof the nucleotide sequence of that fragment within the whole nucleicacid.

Another embodiment of the invention is directed to methods fordetermining a nucleotide sequence by hybridization comprising the stepsof creating a set of nucleic acid probes wherein each probe has adouble-stranded portion, a single-stranded portion, and a randomsequence within the single-stranded portion which is determinable,hybridizing a nucleic acid target which is at least partysingle-stranded to the set, ligating the hybridized target to the probe,and determining the nucleic sequence of the target which is hybridizedto the single-stranded portion of any probe. This embodiment adds a stepwherein the hybridized target is ligated to the probe. Ligation of thetarget nucleic acid to the complimentary probe increases fidelity ofhybridization and allows for incorrectly hybridized target to be easilywashed from correctly hybridized target (FIG. 11). More importantly, theaddition of a ligation step allows for hybridization to be performedunder a single set of hybridization conditions. For example,hybridization temperature is preferably between about 22°-37° C., thesalt concentration useful is preferably between about 0.05-0.5M, and theperiod of hybridization is between about 1-14 hours. This is notpossible using the methodologies of the current procedures which do notemploy a ligation step and represents a very substantial improvement.Ligation can be accomplished using a eukaryotic derived or a prokaryoticderived ligase. Preferred is T4 DNA or RNA ligase. Methods for use ofthese and other nucleic acid modifying enzymes are described in CurrentProtocols in Molecular Biology (F. M. Ausubel et al., editors, JohnWiley & Sons, 1989), which is herein specifically incorporated byreference.

There are a number of distinct advantages to the incorporation of aligation step. First and foremost is that one can use identicalhybridization conditions for hybridization. Variation of hybridizationconditions due to base composition are no longer relevant as nucleicacids with high A/T or G/C content ligate with equal efficiency.Consequently, discrimination is very high between matches andmis-matches, much higher than has been achieved using othermethodologies such as Southern (1989) wherein the effects of G/C contentwere only somewhat neutralized in high concentrations of quarternary ortertiary amines (e.g., 3M tetramethyl ammonium chloride in Drmanac etal., 1993).

Another embodiment of the invention is directed to methods fordetermining a nucleotide sequence by hybridization which comprises thesteps of creating a set of nucleic acid probes wherein each probe has adouble-stranded portion, a single-stranded portion, and a randomsequence within the single-stranded portion which is determinable,hybridizing a target nucleic acid which is at least partlysingle-stranded to the set of nucleic acid probes, enzymaticallyextending a strand of the probe using the hybridized target as atemplate, and determining the nucleotide sequence of the single-strandedportion of the target nucleic acid. This embodiment of the invention issimilar to the previous embodiment, as broadly described herein, andincludes all of the aspects and advantages described therein. Analternative embodiment also includes a step wherein hybridized target isligated to the probe. Ligation increases the fidelity of thehybridization and allows for a more stringent wash step whereinincorrectly hybridized, unligated target can be removed and further,allows for a single set of hybridization conditions to be employed. Mostnonligation techniques including Southern (1989), Drmanac et al. (1993),and Khrapko et al. (1989 and 1991), are only accurate, and onlymarginally so, when hybriizations are performed under optimal conditionswhich vary with the G/C content of each interaction. Preferablecondiions comprise a hybridization temperature of between about 22°-37°C., a salt concentration of betwen about 0.05-0.5M, and a hybridizationperiod of between about 1-14 hours.

Hybridization produces either a 5' overhang or a 3' overhang of targetnucleic acid. Where there is a 5' overhang, a 3-hydroxyl is available onone strand of the probe from which nucleotide addition can be initiated.Preferred enzymes for this process include eukaryotic or prokaryoticpolymerases such as T3 or T7 polymerase, Klenow fragment, or Taqpolymerase. Each of these enzymes are readily available to those ofordinary skill in the art as are procedures for their use (CurrentProtocols in Molecular Biology).

Hybridized probes may also be enzymatically extended a predeterminedlength. For example, reaction condition can be established wherein asingle dNTP or ddNTP is utilized as substrate. Only hybridized probeswherein the first nucleotide to be incorporated is complimentary to thetarget sequence will be extended, thus, providing additionalhybridization fidelity and additional information regarding thenucleotide sequence of the target. Sanger (1977) or Maxam and Gilbert(1977) sequencing can be performed which would provide further targetsequence data. Alternatively, hybridization of target to probe canproduces 3' extensions of target nucleic acids. Hybridized probes can beextended using nucleoside biphosphate substrates or short sequenceswhich are ligated to the 5' terminus.

Another embodiment of the invention is directed to a method fordetermining a nucleotide sequence of a target by hybridizationcomprising the steps of creating a set of nucleic acid probes whereineach probe has a double-stranded portion, a single-stranded portion, anda random nucleotide sequence within the single-stranded portion which isdeterminable, cleaving a plurality of nucleic acid targets to formfragments of various lengths which are at least partly single-stranded,hybridizing the single-stranded region of the fragments with thesingle-stranded region of the probes, identifying the nucleotidesequences of the hybridized portions of the fragments, and comparing theidentified nucleotide sequences to determine the nucleotide sequence ofthe target. An alternative embodiment includes a further step whereinthe hybridized fragments are ligated to the probes prior to identifyingthe nucleotide sequences of the hybridized portions of the fragments. Asdescribed herein, the addition of a ligation step allows forhybridizations to be performed under a single set of hybridizationconditions.

In these embodiments, target nucleic acid is partially cleaved forming aplurality of nucleic acid fragments of various lengths, a nested set,which is then hybridized to the probe. It is preferred that cleavageoccurs by enzymatic, chemical or physical means. Preferred enzymes forpartial cleavage are exonuclease III, S1 nuclease, DNase I, Bal 31, mungbean nuclease, P1 nuclease, lambda exonuclease, restrictionendonuclease, and RNase I. Preferred means for chemical cleavage areultraviolet light induced cleavage, ethidium bromide induced cleavage,and cleavage induced with acid or base. Preferred means for mechanicalcleavage are shearing through direct agitation such as vortexing ormultiple cycles of freeze-thawing. Procedures for enzymatic, chemical orphysical cleavage are disclosed in, for example, Molecular Cloning: ALaboratory Manual (T. Maniatis et al., editors, Cold Spring Harbor1989), which is herein specifically incorporated by reference.

Fragmented target nucleic acids will have a distribution of terminalsequences which is sufficiently broad so that the nucleotide sequence ofthe hybridized fragments will include the entire sequence of the targetnucleic acid. A preferred method is wherein the set of nucleic acidprobes is fixed to a solid support. A preferred solid support is aplastic, a ceramic, a metal or magnetic substance, a resin, a film orother polymer, a gel, or a membrane, and it is more preferred that thesolid support be a two-dimensional or three-dimensional matrix withmultiple probe binding sites such as a hybridization chip as describedby K. R. Khrapko et al. (J. DNA Sequencing and Mapping 1:357-88, 1991).It is also preferred wherein the target nucleic acid has a detectablelabel such as a radioisotope, a stable isotope, an enzyme, a fluorescentchemical, a luminescent chemical, a chromatic chemical, a metal, anelectric charge, or a spatial structure.

As an extension of this procedure, it is also possible to use themethods herein described to determine the nucleotide sequence of one ormore probes which hybridize with an unknown target sequence. Forexample, fragmented targets could be terminally or internally labeled,hybridized with a set of nucleic acid probes, and the hybridizedsequences of the probes determined. This aspect may be useful when it iscumbersome to determine the sequence of the entire target and only asmaller region of that sequence is of interest.

Another embodiment of the invention is directed a method wherein thetarget nucleic acid has a first detectable label at a terminal site anda second detectable label at an internal site. The labels may be thesame type of label or of different types as long as each can bediscriminated, preferably by the same detection method. It is preferredthat the first and second detectable labels are chromatic or fluorescentchemicals or molecules which are detectable by mass spectrometry. Usinga double-labeling method coupled with analysis by mass spectrometryprovides a very rapid and accurate sequencing methodology that can beincorporated in sequencing by hybridization and lends itself very wellto automation and computer control.

Another embodiment of the invention is directed to methods for creatinga nucleic acid probe comprising the steps of synthesizing a plurality ofsingle-stranded first nucleic acids and an array of longersingle-stranded second nucleic acids complimentary to the first nucleicacid with a random terminal nucleotide sequence, hybridizing the firstnucleic acids to the second nucleic acids to form hybrids having adouble-stranded portion and a single-stranded portion with the randomnucleotide sequence within the single-stranded portion, hybridizing asingle-stranded nucleic acid target to the hybrids, ligating thehybridized target to the first nucleic acid of the hybrid, isolating thesecond nucleic acid, and hybridizing the first nucleic acid of step withthe isolated second nucleic acid to form a nucleic acid probe. Probescreated in this manner are referred to herein as customized probes.

Preferred customized probe comprises a first nucleic acid which is about15-25 nucleotides in length and the second nucleic acid is about 20-30nucleotides in length. It is also preferred that the double-strandedportion contain an enzyme recognition site which allows for increasedflexibility of use and facilitates cloning, should it at some pointbecome desirable to clone one or more of the probes. It is alsopreferred if the customized probe is fixed to a solid support, such as,a plastic, a ceramic, a metal, a resin, a film or other polymer, a gel,or a membrane, or possibly a two- or three-dimensional array such as achip or microchip.

Customized probes, created by the method of this invention, have a widerange of uses. These probes are, first of all, structurally useful foridentifying and binding to only those sequences which are homologous tothe overhangs. Secondly, the overhangs of these probes possess thenucleotide sequence of interest. No further manipulation is required tocarry the sequence of interest to another structure. Therefore, thecustomized probes greatly lend themselves to use in, for example,diagnostic aids for the genetic screening of a biological sample.

Another embodiment of the invention is directed to arrays of nucleicacid probes wherein each probe comprises a double-stranded portion oflength D, a terminal single-stranded portion of length S, and a randomnucleotide sequence within the single-stranded portion of length R.Preferably, D is between about 3-20 nucleotides and S is between about3-20 nucleotides and the entire array is fixed to a solid support whichmay be composed of plastics, ceramics, metals, resins, polymers andother films, gels, membranes and two-dimensional and three-dimensionalmatrices such as hybridization chips or microchips. Probe arrays areuseful in sequencing and diagnostic applications when the sequenceand/or position on a solid support of every probe of the array is knownor is unknown. In either case, information about the target nucleic acidmay be obtained and the target nucleic acid detected, identified andsequenced as described in the methods described herein. Arrays comprise4^(R) different probes representing every member of the random sequenceof length R, but arrays of less than 4^(R) are also encompassed by theinvention.

Another embodiment of the invention is directed to method for creatingprobe arrays comprising the steps of synthesizing a first set of nucleicacids each comprising a constant sequence of length C at a 3'-terminusand a random sequence of length R at a 5'-terminus, synthesizing asecond set of nucleic acids each comprising a sequence complimentary tothe constant sequence of each of the first nucleic acid, and hybridizingthe first set with the second set to create the array. Preferably, thenucleic acids of the first set are each between about 15-30 nucleotidesin length and the nucleic acids of the second set are each between about10-25 nucleotides in length. Also preferable is that C is between about7-20 nucleotides and R is between about 3-10 nucleotides.

Arrays may comprise about 4^(R) different probes, but in certainapplications, an entire array of every possible sequence is notnecessary and incomplete arrays are acceptable for use. For example,incomplete arrays may be utilized for screening procedures of very raretarget nucleic acids where nonspecific hybridization is not expected tobe problematic. Further, every member of an array may not be needed whendetecting or sequencing smaller nucleic acids where the chance ofrequiring certain combinations of nucleotides is so low as to bepractically nonexistent. Array which are fixed to solid supports areexpected to be most useful, although array in solution also have manyapplications. Solid supports which are useful include plastics such asmicrotiter plates, beads and microbeads, ceramics, metals whereresilience is desired or magnetic beads for ease of isolation, resins,gels, polymers and other films, membranes or chips such as the two- andthree-dimensional sequencing chips utilized in sequencing technology.

Alternatively, probe arrays may also be made which are single-stranded.These arrays are created, preferably on a solid support, basically asdescribed, by synthesizing an array of nucleic acids each comprising aconstant sequence of length C at a 3'-terminus and a random sequence oflength R at a 5'-terminus, and fixing the array to a first solidsupport. Arrays created in this manner can be quickly and easilytransformed into double-stranded arrays by the synthesis andhybridization of a set of nucleic acids with a sequence complimentary tothe constant sequence of the replicated array to create adouble-stranded replicated array. However, in their present form,single-stranded arrays are very valuable as templates for replication ofthe array.

Due to the very large numbers of probes which comprise most usefularrays, there is a great deal of time spent in simply creating thearray. It requires many hours of nucleic acid synthesis to create eachmember of the array and many hours of manipulations to place the arrayin an organized fashion onto any solid support such as those describedpreviously. Once the master array is created, replicated arrays orslaves, can be quickly and easily created by the methods of theinvention which take advantage of the speed and accuracy of nucleic acidpolymerases. Basically, methods for replicating an array ofsingle-stranded probes on a solid support comprise the steps ofsynthesizing an array of nucleic acids each comprising a constantsequence of length C at a 3'-terminus and a random sequence of length Rat a 5'-terminus, fixing the array to a first solid support,synthesizing a set of nucleic acids each comprising a sequencecomplimentary to the constant sequence, hybridizing the nucleic acids ofthe set with the array, enzymatically extending the nucleic acids of theset using the random sequences of the array as templates, denaturing theset of extended nucleic acids, and fixing the denatured nucleic acids ofthe set to a second solid support to create the replicated array ofsingle-stranded probes.

Denaturation of the array can be performed by subjecting the array toheat, for example 90°-100° C. for 2-15 minutes, or highly alkalineconditions, such as by the addition of sodium hydroxide. Denaturationcan also be accomplished by adding organic solvents, nucleic acidbinding proteins or enzymes which promote denaturation to the array.Preferably, the solid supports are coated with a substance such asstreptavidin and the nucleic acid reagents conjugated with biotin.Denaturation of the partial duplex leads to binding of the nucleic acidsto the solid support.

Another embodiment of the invention is directed to methods for creatingarrays of probes comprising the steps of synthesizing an array ofsingle-stranded nucleic acids each containing a constant sequence at the3'-terminus, another constant sequence at the 5'-terminus, and a randominternal sequence of length R flanked by the cleavage site(s) of arestriction enzyme (on one or both sides), synthesizing an array ofprimers each compliementary to a portion of the constant sequence of the3'-terminus, hybridizing the two arrays together to form hybrids,extending the sequence of each primer by polymerization using a sequenceof the nucleic acid as a template, and cleaving the extended hybridswith the restriction enzyme to form an array of probes with adouble-stranded portion at one terminus, a single-stranded portioncontaining the random sequence at the opposite terminus. Preferably, thenucleic acids are each between about 10-50 nucleotides in length and Ris between about 3-5 nucleotides in length. Any of the restrictionenzymes which produce a 3'- or 5'-overhang after cleavage are suitablefor use to make the array. Some of the restriction enzymes which areuseful in this regard, and their recognition sequences are depicted inTable 1.

                                      TABLE 1                                     __________________________________________________________________________    Restriction                                                                        Recognition Sequence                                                     Enzyme                                                                             5'-Overhang       3'-Overhang                                            __________________________________________________________________________    AlwN I                                                                             5'-CAG NNN↓CTG                                                         3'-GTC↑NNN GAC                                                     Bbv I                                                                              5'-GCAGC(N).sub.8 ↓ (SEQ ID NO 37)                                     3'-CGTCG(N).sub.12 ↑ (SEQ ID NO 38)                                Bgl I                                                                              5'-GCCN NNN↓NGGC (SEQ ID NO 39)                                        3'CGGN↑NNN NCCG (SEQ ID NO 39)                                     BstX I                 5'-CCAN NNNN↓NTGG (SEQ ID NO 40)                                       3'-GGTN↑NNNN NACC (SEQ ID NO 40)                 Dra III                                                                            5'-CAC NNN↓GTG                                                         3'-GTG↑NNN CAC                                                     Fok I                                                                              5'-GGATG(N).sub.9 ↓ (SEQ ID NO 41)                                     3'-CCTAC(N).sub.13 ↑ (SEQ ID NO 42)                                Hga I                                                                              5'-GACGC(N).sub.5 ↓ (SEQ ID NO 43)                                     3'-CTGCG(N).sub.10 ↑ (SEQ ID NO 44)                                PflM I                 5'-CCAN NNN↓NTGG (SEQ ID NO 45)                                        3'-GGTN↑NNN NACC (SEQ ID NO 45)                  SfaN I                                                                             5'-GCATC(N).sub.5 ↓ (SEQ ID NO 46)                                     3'-CGTAG(N).sub.9 ↑ (SEQ ID NO 47)                                 Dfi I                  5'-GGCCN NNN↓NGGCC (SEQ ID NO 48)                                      3'-CCGGN↑NNN NCCGG (SEQ ID NO                    __________________________________________________________________________                           48)                                                

Also prefered is that the array be fixed to a solid support such as aplastic, ceramic, metal, resin, polymer, gel, film, membrane or chip.Fixation can be accomplished by conjugating the reagents for synthesiswith a specific binding protein or other similar substance and coatingthe surface of the support with the binding counterpart (e.g.biotin/streptavidin, F_(c) /protein A, nucleic acid/nucleic acid bindingprotein).

Alternatively, another similar method for creating an array of probescomprising the steps of synthesizing an array of single-stranded nucleicacids each containing a constant sequence at the 3'-terminus, anotherconstant sequence at the 5'-terminus, and a random internal sequence oflength R flanked by the cleavage site(s) of a restriction enzyme (on oneor both sides), synthesizing an array of primers with a sequencecomplimentary to the constant sequence at the 3'-terminus, hybridizingthe two arrays together to form hybrids, enzymatically extending theprimers using the nucleic acids as templates to form full-lengthhybrids, cloning the full-length hybrids into vectors such as plasmidsor phage, cloning the plasmids into competent bacteria or phage,reisolating the cloned plasmid DNA, amplifying the cloned sequences bymultiple polymerase chain reactions, and cleaving the amplifiedsequences with the restriction enzyme to form the array of probes with adouble-stranded portion at one terminus and a single-stranded portioncontaining the random sequence at the opposite terminus. Using thismethod the array of probes may have 5'- or 3'-overhangs depending on thecleavage specificity of the restriction enzyme (e.g. Table 1). The arrayof probes may be fixed to a solid support such as a plastic, ceramic,metal, resin, polymer, film, gel, membranes and chip. Preferably, duringPCR amplification, the reagent primers are conjugated with biotin whichfacilitates eventual binding to a streptavidin coated surface.

Another embodiment of the invention is directed to methods for usingcustomized probes, arrays, and replicated arrays, as described herein,in diagnostic aids to screen biological samples for specific nucleicacid sequences. Diagnostic aids and methods for using diagnostic aidswould be very useful when sequence information at a particular locus of,for example, DNA is desired. Single nucleotide mutations or more complexnucleic acid fingerprints can be identified and analyzed quickly,efficiently, and easily. Such an approach would be immediately usefulfor the detection of individual and family genetic variation, ofinherited mutations such as those which cause a disease, DNA dependentnormal phenotypic variation, DNA dependent somatic variation, and thepresence of heterologous nucleic acid sequences.

Especially useful are diagnostic aids comprising probe arrays. Thesearrays can make the detection identification, and sequencing of nucleicacids from biological samples exceptionally rapid and allows one toobtain multiple pieces of information from a single sample afterperforming a single test. Methods for detecting and/or identifying atarget nucleic acid in a biological sample comprise the steps ofcreating an array of probes fixed to a solid support as describedherein, labeling the nucleic acid of the biological sample with adetectable label, hybridizing the labeled nucleic acid to the array anddetecting the sequence of the nucleic acid from a binding pattern of thelabel on the array. These methods for creating probe arrays and forrapidly and efficiently replicating those arrays, such as for diagnosticaids, makes the manufacture and commercial application of large numbersof arrays a possibility.

As described, these diagnostic aids are useful to humans, other animals,and even plants for the detection of infections due to viruses,bacteria, fungi or yeast, and for the detection of certain parasites.These detection methods and aids are also useful in the feed and foodindustries and in the environmental field for the detection,identification and sequencing of nucleic acids associated with samplesobtained from environmental sources and from manufacturing products andby-products.

Diagnostic aids comprise specific nucleic acid probes fixed to a solidsupport to which is added the biological sample. Hybridization of targetnucleic acids is determined by adding a detectable label, such as alabeled antibody, which will specifically recognize only hybridizedtargets or, alternatively, unhybridized target is washed off and labeledtarget specific antibodies are added. In either case, appearance oflabel on the solid support indicates the presence of nucleic acid targethybridized to the probe and consequently, within the biological sample.

Customized probes may also prove useful in prophylaxis or therapy bydirecting a drug, antigen, or other substance to a nucleic acid targetwith which it will hybridize. The substance to be targeted can be boundto the probe so as not to interfere with possible hybridization. Forexample, if the probe was targeted to a viral nucleic acid target, aneffective antiviral could be bound to the probe which will then be ableto specifically carry the antiviral to infected cells. This would beespecially useful when the treatment is harmful to normal cells andprecise targeting is required for efficacy.

Another embodiment of the invention is directed to methods for creatinga nucleic acid probe comprising the steps of synthesizing a plurality ofsingle-stranded first nucleic acids and an array of longersingle-stranded second nucleic acids complimentary to the first nucleicacid with a random terminal nucleotide sequence, hybridizing the firstnucleic acids to the second nucleic acids to form hybrids having adouble-stranded portion and a single-stranded portion with the randomnucleotide sequence within the single-stranded portion, hybridizing asingle-stranded nucleic acid target to the hybrids, ligating thehybridized target to the first nucleic acid of the hybrid, hybridizingthe ligated hybrid with an array of oligonucleotides with randomnucleotide sequences, ligating the hybridized oligonucleotide to thesecond nucleic acid of the ligated hybrid, isolating the second nucleicacid, and hybridizing another first nucleic acid with the isolatedsecond nucleic acid to form a nucleic acid probe. Preferred is that thefirst nucleic acid is about 15-25 nucleotides in length, that the secondnucleic acid is about 20-30 nucleotides in length, that the constantportion contain an enzyme recognition site, and that theoligonucleotides are each about 4-20 nucleotides in length. Probes maybe fixed to a solid support such as a plastic, ceramic, a metal, aresin, a gel, or a membrane. It is preferred that the solid support be atwo-dimensional or three-dimensional matrix with multiple probe bindingsites such as a hybridization chip. Nucleic acid probes created by themethod of the present invention are useful in a diagnostic aid to screena biological sample for genetic variations of nucleic acid sequencestherein.

Another embodiment of the invention is directed to a method for creatinga nucleic acid probe comprising the steps of (a) synthesizing aplurality of single-stranded first nucleic acids and a set of longersingle-stranded second nucleic acids complimentary to the first nucleicacid with a random terminal nucleotide sequence, (b) hybridizing thefirst nucleic acids to the second nucleic acids to form hybrids having adouble-stranded portion and a single-stranded portion with the randomnucleotide sequence in the single-stranded portion, (c) hybridizing asingle-stranded nucleic acid target to the hybrids, (d) ligating thehybridized target to the first nucleic acid of the hybrid, (e)enzymatically extending the second nucleic acid using the target as atemplate, (f) isolating the extended second nucleic acid, and (g)hybridizing the first nucleic acid of step (a) with the isolated secondnucleic acid to form a nucleic acid probe. It is preferred that thefirst nucleic acid is about 15-25 nucleotides in length, that the secondnucleic acid is about 20-30 nucleotides in length, and that thedouble-stranded portion contain an enzyme recognition site. It is alsopreferred that the probe be fixed to a solid support, such as a plastic,ceramic, a metal, a resin, a gel, or a membrane. A preferred solidsupport is a two-dimensional or three-dimensional matrix with multipleprobe binding sites, such as a hybridization chip. A further embodimentof the present invention is a diagnostic aid comprising the creatednucleic acid probe and a method for using the diagnostic aid to screen abiological sample as herein described.

As an extension of this procedure, it is also possible to use themethods herein described to determine the nucleotide sequence of one ormore probes which hybridize with an unknown target sequence. Forexample, Sanger dideoxynucleotide sequencing techniques could be usedwhen enzymatically extending the second nucleic acid using the target asa template and labeled substrate, extended products could be resolved bypolyacrylamide gel electrophoresis, and the hybridized sequences of theprobes easily read off the gel. This aspect may be useful when it iscumbersome to determine the sequence of the entire target and only asmaller region of that sequence is of interest.

The following examples illustrate embodiments of the invention, butshould not be viewed as limiting the scope of the invention.

EXAMPLES Example 1

Manipulation of DNA in the solid state. Complexes between streptavidin(or avidin) and biotin represent the standard way in which much solidstate DNA sequencing or other DNA manipulation is done, and one of thestandard ways in which non-radioactive detection of DNA is carried out.Over the past few years streptavidin-biotin technology has expanded inseveral ways. Several years ago, the gene for streptavidin was clonedand sequenced (C. E. Argarana et al., Nuc. Acids Res. 14:1871, 1986).More recently, using the Studier T7 system, over-expression of theProtein in E. coli was achieved (T. Sano and C. R. Cantor, Proc. Natl.Acad. Sci. USA 87:142, 1990). In the last year, mutant streptavidinsmodified for improved solubility properties and firmer attachment tosolid supports was also expressed (T. Sano and C. R. Cantor,Bio/Technology 9:1378-81, 1993). The most relevant of these is corestreptavidin, (fully active protein with extraneous N- and C-terminalpeptides removed) with 5 cysteine residues attached to the C-terminus.An active protein fusion of streptavidin to two IgG binding domains ofstaphylococcal A protein was also produced (T. Sano and C. R. Cantor,Bio/Technology 9:1378-81, 1991). This allowed biotinylated DNAs to beattached to specific Immunoglobulin G molecules without the need for anycovalent chemistry, and it has led to the development of immuno-PCR, anexceedingly sensitive method for detecting antigens (T. Sano et al.,Sci. 258:120-29, 1992).

A protein fusion between streptavidin and metallothionein was recentlyonstructed (T. Sano et al., Proc. Natl. Acad. Sci. USA, 1992). Bothpartners in this protein fusion are fully active and thesestreptavidin-biotin interactions are being used to develop new methodsfor purification of DNA, including triplex-mediated capture of duplexDNA on magnetic microbeads (T. Ito et al., Proc. Natl. Acad. Sci. USA89:495-98, 1992) and affinity capture electrophoresis of DNA in agarose(T. Ito et al., G.A.T.A., 1992).

An examination of the potential advantages of stacking hybridization hasbeen carried out by both calculations and pilot experiments. Somecalculated T_(m) 's for perfect and mismatched duplexes are shown inFIG. 1. These are based on average base compositions. The calculationswere preformed using the equations given by J. G. Wetmur (Crit. Rev. inBiochem. and Mol. Biol. 26:227-59, 1991). In the case of oligonucleotidestacking, these researchers assumed that the first duplex is fullyformed under the conditions where the second oligomer is being tested;in practice this may not always be the case. It will, however, be thecase for the configuration shown in FIG. 1. The calculations reveal anumber of interesting features about stacking hybridization. Note thatthe binding of a second oligomer next to a pre-formed duplex provides anextra stability equal to about two base pairs. More interesting, still,is the fact that mispairing seems to have a larger consequence onstacking hybridization than it does on ordinary hybridization. This isconsistent with the very large effects seen by K. R. Khrapko et al. (J.DNA Sequencing and Mapping 1:375-88, 1991) for certain types ofmispairing. Other types of mispairing are less destabilizing, but thesecan be eliminated by requiring a ligation step. In standard SBH, aterminal mismatch is the least destabilizing event, and thus, leads tothe greatest source of ambiguity or background. For an octanucleotidecomplex, an average terminal mismatch leads to a 6° C. lowering inT_(m). For stacking hybridization, a terminal mismatch on the side awayfrom the pre-existing duplex, is the least destabilizing event. For apentamer, this leads to a drop in T_(m) of 10° C. These considerationsindicate that the discrimination power of stacking hybridization infavor of perfect duplexes might be greater than ordinary SBH.

Example 2

Terminal sequencing by positional hybridization. The basic sequencing byhybridization scheme is depicted in FIG. 2. It is different from anyother because it uses a duplex oligonucleotide array with 3'-endedsingle-stranded overhangs. The duplex portion of each DNA shown isconstant. Only the overhangs vary, and in principle an array of 4^(n)probes is needed to represent all possible overhangs of length n. Theadvantage of such an array is that it provides enhanced sequencestringency in detecting the 5' terminal nucleotide of the target DNAbecause of base stacking between the preformed DNA duplex and the newlyformed duplex.

One variable is the length of the single-stranded overhang. The shorterthe overhang, the smaller the array of probes potentially useable.Overhangs of five and six have been successfully employed. The nature ofthe support surface to which the oligonucleotide is attached, the meansof its attachment, and the length of the oligonucleotide duplex are alsoimportant variables. Initially one 5' end-biotinylated strand of theprobe duplex is attached to a solid surface. The technology is alreadywell developed for the attachment of nucleic acids to solid supports,such as streptavidin-coated magnetic microbeads and membranes such asthe thin gel system.

Another variable is the nucleic acid capacity of the immobilized spot ofprobe. This determines the detection sensitivity required and is alsoimportant where unlabeled DNA may be present that could hybridizecompetitively with the desired labeled DNA product. As depicted in FIG.2A, the 3' overhang of the array can detect the 3'-terminal sequence ofthe target DNA. These will derive from 5'-end labeled restrictionfragments of known DNA sequence cut from vectors so that the target forthe immobilized probe will either be at the 3' end, just internal to it,or totally internal. In some subsequent examples, it does not matterwhether hybridization is absolutely specific for the 3' end.

Alternatively, positional sequencing by hybridization of the 5'-endsingle-stranded overhangs would be equally effective (FIG. 2B). Thispermits reading of the 5' terminal sequence of the target DNA. However,this approach is not as versatile because it does not allow for the useof polymerases to enhance the length and accuracy of the sequence read.

Example 3

Preparation of model arrays. Following the scheme shown in FIG. 2, in asingle synthesis, all 1024 possible single-stranded probes with aconstant 18 base stalk followed by a variable 5 base extension can becreated. The 18 base extension is designed to contain two restrictionenzyme cutting sites. Hga I generates a 5 base, 5' overhang consistingof the variable bases N₅. Not I generates a 4 base, 5' overhang at theconstant end of the oligonucleotide. The synthetic 23-mer mixture willbe hybridized with a complimentary 18-mer to form a duplex which canthen be enzymatically extended to form all 1024, 23-mer duplexes. Thesecan be cloned by, for example, blunt end ligation, into a plasmid whichlacks Not I sites. Colonies containing the cloned 23-base insert can beselected. Each should be a clone of one unique sequence. DNA miniprepscan be cut at the constant end of the stalk, filled in with biotinylatedpyrimidines, then cut at the variable end of the stalk to generate the 5base 5' overhang. The resulting nucleic acid can be fractionated byQiagen columns (nucleic acid purification columns) to discard the highmolecular weight material, and the nucleic acid probe will then beattached to a streptavidin-coated surface. This procedure could easilybe automated in a Beckman Biomec or equivalent chemical robot to producemany identical arrays of probes.

The initial array contains about a thousand probes. The particularsequence at any location in the array will not be known. However, thearray can be used for statistical evaluation of the signal to noiseratio and the sequence discrimination for different target moleculesunder different hybridization conditions. Hybridization with knownnucleic acid sequences allows for the identification of particularelements of the array. A sufficient set of hybridizations would trainthe array for any subsequent sequencing task. Arrays are partiallycharacterized until they have the desired properties. For example, thelength of the oligonucleotide duplex, the mode of its attachment to asurface, and the hybridization conditions used, can all be varied, usingthe initial set of cloned DNA probes. Once the sort of array that worksbest is determined, a complete and fully characterized array can then beconstructed by ordinary chemical synthesis.

Example 4

Preparation of specific probe arrays. The major challenge for positionalSBH, is to build real arrays of probes, and test the fraction ofsequences that actually perform according to expectations. Basecomposition and base sequence dependence on the effectiveness ofhybridization is probably the greatest obstacle to successfulimplementation of these methods. The use of enzymatic steps, wherefeasible, may simplify these problems, since, after all, the enzymes domanage to work with a wide variety of DNA sequences in vivo. Withpositional SBH, one potential trick to compensate for some variations instability would be to allow the adjacent duplex to vary. Thus, for anA+T rich overhang, one could use a G+C rich stacking duplex, and viceversa.

Four methods for making arrays are tested and evaluated with two majorobjectives. The first is to produce, rapidly and inexpensively, arraysthat will test some of the principles of positional SBH. The second isto develop effective methods for the automated preparation of fullarrays needed for production sequencing via positional SBH. Since thefirst studies indicated that a five base overhang will be sufficient,arrays may only have to have 1024 members. The cost of making all ofthese compounds is actually quite modest. The constant portion of theprobes can be made once, and then extended in parallel, by automated DNAsynthesis methods. In the simplest case, this will require the additionof only 5 bases to each of 1024 compounds, which at typical chemicalcosts of $2 per base will amount to a total of about $10,000.

Moderately dense arrays can be made using a typical x-y robot to spotthe biotinylated compounds individually onto a streptavidin-coatedsurface. Using such robots, it is possible to make arrays of 2×10⁴samples in 100 to 400 cm² of nominal surface. T array should preferablyfit in 10 cm², but even if forced, for unforeseen technical reasons, tocompromise on an array ten times or even 50 times less dense, it will bequite suitable for testing the principles of and many of the variationson positional SBH. Commercially available streptavidin-coated beads canbe adhered, permanently to plastics like polystyrene, by exposing theplastic first to a brief treatment with an organic solvent liketriethylamine. The resulting plastic surfaces have enormously highbiotin binding capacity because of the very high surface area thatresults. This will suffice for radioactively labeled samples.

For fluorescently labeled samples, the background scattering from such abead-impregnated sample may interfere. In this case, astreptavidin-conjugated glass or plastic surface may be utilized(commercially available from Bios Products). Surfaces are made usingcommercially available amine-containing surfaces and using commerciallyavailable biotin-containing N-hydroxysuccinimide esters to make stablepeptide conjugates. The resulting surfaces will bind streptavidin, atone biotin binding site (or at most two, but not more because theapproximate 222 symmetry of the protein would preclude this), whichwould leave other sites available for binding to biotinylatedoligonucleotides.

In certain experiments, the need for attaching oligonucleotides tosurfaces may be circumvented altogether, and oligonucleotides attachedto streptavidin-coated magnetic microbeads used as already done in pilotexperiments. The beads can be manipulated in microtitre plates. Amagnetic separator suitable for such plates can be used including thenewly available compressed plates. For example, the 18 by 24 well plates(Genetix, Ltd.; USA Scientific Plastics) would allow containment of theentire array in 3 plates; this formate is well handled by existingchemical robots. It is preferable to use the more compressed 36 by 48well formate, so that the entire array would fit on a single plate. Theadvantages of this approach for all the experiments are that anypotential complexities from surface effects can be avoided, andalready-existing liquid handling, thermal control, and imaging methodscan be used for all the experiments. Thus, this allows thecharacterization of many of the features of positional SBH before havingto invest the time and effort in fabricating instruments, tools andchips.

Lastly, a rapid and highly efficient method to print arrays has beendeveloped. Master arrays are made which direct the preparation ofreplicas, or appropriate complementary arrays. A master array is mademanually (or by a very accurate robot) by sampling a set of custom DNAsequences in the desired pattern and then transferring these sequencesto the replica. The master array is just a set of all 1024-4096compounds. It is printed by multiple headed pipettes and compressed byoffsetting. A potentially more elegant approach is shown in FIG. 14. Amaster array is made and used to transfer components of the replicas ina sequence-specific way. The sequences to be transferred are designed sothat they contain the desired 5 or 6 base 5' variable overhang adjacentto a unique 15 base DNA sequence.

The master array consists of a set of streptavidin bead-impregnatedplastic coated metal pins, each of which, at its tip, containsimmobilized biotinylated DNA strands that consist of the variable 5 or 6base segment plus the constant 15 base segment. Any unoccupied sites onthis surface are filled with excess free biotin. To produce a replicachip, the master array is incubated with the complement of the 15 baseconstant sequence, 5' -labeled with biotin. Next, DNA polymerase is usedto synthesize the complement of the 5 or 6 base variable sequence. Thenthe wet pin array is touched to the streptavidin-coated surface of thereplica, held at a temperature above the T_(m) of the complexes on themaster array. If there is insufficient liquid carryover from the pinarray for efficient sample transfer, the replica array could first becoated with spaced droplets of solvent (either held in concave cavities,or delivered by a multiheaded pipettor). After the transfer, the replicachip is incubated with the complement of 15 base constant sequence toreform the double-stranded portions of the array. The basic advantage ofthis scheme, if it can be realized, is that the master array andtransfer compounds are made only once, and then the manufacture ofreplica arrays should be able to proceed almost endlessly.

Example 5

DNA ligation to oligonucleotide arrays. Following the schemes shown inFIGS. 3A and 3B, E. coli and T4 DNA ligases can be used to covalentlyattach hybridized target nucleic acid to the correct immobilizedoligonucleotide probe. This is a highly accurate and efficient process.Because ligase absolutely requires a correctly base paired 3' terminus,ligase will read only the 3'-terminal sequence of the target nucleicacid. After ligation, the resulting duplex will be 23 base pairs longand it will be possible to remove unhybridized, unligated target nucleicacid using fairly stringent washing conditions. Appropriately chosenpositive and negative controls demonstrate the power of this scheme,such as arrays which are lacking a 5'-terminal phosphate adjacent to the3' overhang since these probes will not ligate to the target nucleicacid.

There are a number of advantages to a ligation step. Physicalspecificity is supplanted by enzymatic specificity. Focusing on the 3'end of the target nucleic also minimize problems arising from stablesecondary structures in the target DNA. As shown in FIG. 3B, ligationcan be used to enhance the fidelity of detecting the 5'-terminalsequence of a target DNA.

DNA ligases are also used to covalently attach hybridized target DNA tothe correct immobilized oligonucleotide probe. Several tests of thefeasibility of the ligation scheme shown in FIG. 3. Biotinylated probeswere attached to streptavidin-coated magnetic microbeads, and annealedwith a shorter, complementary, constant sequence to produce duplexeswith 5 or 6 base single-stranded overhangs. One set of actual sequencesused is shown in Example 14. ³² P-end labeled targets were allowed tohybridize to the Probes. Free targets were removed by capturing thebeads with a magnetic separator. DNA ligase was added and ligation wasallowed to proceed at various salt concentrations. The samples werewashed at room temperature, again manipulating the immobilized compoundswith a magnetic separator. This should remove non-ligated material.Finally, samples were incubated at a temperature above the T_(m) of theduplexes, and eluted single strand was retained after the remainder ofthe samples were removed by magnetic separation. The eluate at thispoint should consist of the ligated material. The fraction of ligationwas estimated as the amount of ³² p recovered in the high temperaturewash versus the amount recovered in both the high and low temperaturewashes. Results obtained are shown in FIG. 13. It is apparent that saltconditions can be found where the legation proceeds efficiently withperfectly matched 5 or 6 base overhangs, but not with G-T mismatches.

The results of a more extensive set of similar experiments are shown inTables 2-4. Table 2 looks at the effect of the position of the mismatchand Table 3 examines the effect of base composition on the relativediscrimination of perfect matches verses weakly destabilizingmismatches. These data demonstrate that: (1) effective discriminationbetween perfect matches and single mismatches occurs with all five baseoverhangs tested; (2) there is little if any effect of base compositionon the amount of ligation seen or the effectiveness of match/mismatchdiscrimination. Thus, the serious problems of dealing with basecomposition effects on stability seen in ordinary SBH do not appear tobe a problem for positional SBH; and (3) the worst mismatch positionis,as expected, the one distal from the phosphodiester bond formed in theligation reaction. However, any mismatches that survive in this positionwill be eliminatd by a polymerase extension reaction, such as asdescribed herein. provided that polymerase is used, like sequenaseversion 2, that has no 3'-endonuclease activity or terminal transferaseactivity; and (4) gel electrophoresis analysis has confirmed that theputative ligation products seen in these tests are indeed the actualproducts synthesized.

                                      TABLE 2                                     __________________________________________________________________________    Ligation Efficiency of Matched and Mismatched Duplexes                        in 0.2 M NaCl at 37° C.                                                (SEQ ID NO 1) 3'-TCG AGA ACC TTG GCT-5'                                                             Ligation Efficiency                                     __________________________________________________________________________       CTA CTA GGC TGC GTA GTC-5'  (SEQ ID NO 2)                                  5'-B-                                                                            GAT GAT CCG ACG CAT CAG AGC TC                                                                   0.170    (SEQ ID NO 3)                                  5'-B-                                                                            GAT GAT CCG ACG CAT CAG AGC TT                                                                   0.006    (SEQ ID NO 4)                                  5'-B-                                                                            GAT GAT CCG ACG CAT CAG AGC TA                                                                   0.006    (SEQ ID NO 5)                                  5'-B-                                                                            GAT GAT CCG ACG CAT CAG AGC CC                                                                   0.002    (SEQ ID NO 6)                                  5'-B-                                                                            GAT GAT CCG ACG CAT CAG AGT TC                                                                   0.004    (SEQ ID NO 7)                                  5'-B-                                                                            GAT GAT CCG ACG CAT CAG AAC TC                                                                   0.001    (SEQ ID NO 8)                                  __________________________________________________________________________

                  TABLE 3                                                         ______________________________________                                        Ligation Efficiency of Matched and Mismatched Duplexes                        in 0.2 M NaCl at 37° C. and                                            its Dependance on AT Content of the Overhang                                  Overhang Sequences                                                                            AT Content                                                                              Ligation Efficiency                                 ______________________________________                                        Match     GGCCC     0/5       0.30                                            Mismatch  GGCCT               0.03                                            Match     AGCCC     1/5       0.36                                            Mismatch  AGCTC               0.02                                            Match     AGCTC     2/5       0.17                                            Mismatch  AGCTT               0.01                                            Match     AGATC     3/5       0.24                                            Mismatch  AGATT               0.01                                            Match     ATATC     4/5       0.17                                            Mismatch  ATATT               0.01                                            Match     ATATT     5/5       0.31                                            Mismatch  ATATC               0.02                                            ______________________________________                                    

                                      TABLE 4                                     __________________________________________________________________________    Increasing Discrimination by Sequencing Extension at 37° C.                                     Ligation Efficiency                                                                    Ligation Extension (cpm)                                             (percent)                                                                              (+)   (-)                                   __________________________________________________________________________       (SEQ ID NO 1) 3'-TCG AGA ACC TFG GCT-5'*                                      CTA CTA GGC TGC GTA GTC-5'(SEQ ID NO 2)                                    5'-B-                                                                            GAT GAT CCG ACG CAT CAG AGA TC                                                                      0.24      4,934                                                                              29,500                                   (SEQ ID NO 9)                                                              5'-B-                                                                            GAT GAT CCG ACG CAT CAG AGC TT                                                                      0.01       116   250                                    (SEQ ID NO 10)                                                                Discrimination =      ×24                                                                              ×42                                                                           ×118                               (SEQ ID NO 1) 3'-TCG AGA ACC TTG GCT-5'*                                      CTA CTA GGC TGC GTA GTC-5'(SEQ ID NO 2)                                    5'-B-                                                                            GAT GAT CCG ACG CAT CAG ATA TC                                                                      0.17     12,250                                                                              25,200                                   (SEQ ID NO 11)                                                             5'-B-                                                                            GAT GAT CCG ACG CAT CAG ATA TT                                                                      0.01       240   390                                    (SEQ ID NO 12)                                                                Discrimination =      ×17                                                                              ×51                                                                           ×65                             __________________________________________________________________________     "B" = Biotin                                                                  "*" = radioactive label                                                  

The discrimination for the correct sequence is not as great with anexternal mismatch (which would be the most difficult case todiscriminate) as with an internal mismatch (Table 4). A mismatch rightat the ligation point would presumably offer the highest possiblediscrimination. In any event, the results shown are very promising.Already there is a level of discrimination with only 5 or 6 bases ofoverlap that is better than the discrimination seen in conventional SBHwith 8 base overlaps. Allele-specific amplification by the ligase chainreaction also appears to be quite successful (F. Baranay et al., Proc.Natl. Acad. Sci. USA 88:189-93, 1991).

Example 6

Positional sequencing by hybridization with a nested set of DNA samples.Thus far described arrays have been very inefficiently utilized becausewith only a single target nucleic acid, only a single probe will bedetected. This clearly wastes most of the potential informationintrinsically available from the array. A variation in the procedureswill use the array much more efficiently. This is illustrated in FIG. 6.Here, before hybridization to the probe array, the 5'-labeled (orunlabeled) target nucleic acid is partially degraded with an enzyme suchas exonuclease III. Digestion produces a large number of molecules witha range of chain lengths that share a common 5'-terminus, but have avariable 3'-terminus. This entire family of nucleic acids is thenhybridized to the probe array. Assuming that the distribution of 3'-endsis sufficiently broad, the hybridization pattern should allow thesequence of the entire target to be read subject to any branch pointambiguities. If a single set of exonuclease conditions fails to providea broad enough distribution, samples could be combined and preparedunder several different conditions.

There are at least three ways to make nested DNA deletions suitable forpositional SBH. The easiest, but ultimately probably the leastsatisfactory, is to use exonuclease like exonuclease III, by analogy tonested deletion cloning in ordinary sequencing (S. Henikoff, Gene28:351-58, 1984). The difficulty with these enzymes is that they may notproduce an even enough yield of compounds to fully represent the sampleof interest. One sees a pattern of regions in the sequence where theenzyme moves relatively rapidly, and others where it moves relativelyslowly. Several commercially available enzymes can be examined bylooking at the distribution of fragment lengths directly on ordinarypolyacrylamide DNA sequencing gels.

The second approach to making nested samples is to use the ordinaryMaxam-Gilbert sequencing chemistry. It is possible to ligate the5'-phosphorylated fragments which result from these chemicaldegradations. Indeed this is the principle use for ligation-mediatedgenomic DNA sequencing (G. P. Pfiefer et al., Sci. 246:810-13, 1989).Asymmetric PCR or linear amplification can be used to make thecomplementary, ligatable, nested strands. A side benefit of thisapproach is that one can pre-select which base to cleave after, and thisprovides additional information about the DNA sequences one is workingwith.

The third approach to making nested samples is to use variants onplus/minus sequencing. For example, one can make a very even DNAsequencing ladder by using Sanger sequencing with a dideoxy-pppNterminator. This does not produce a ligatable end. However it can bereplaced with a ligatable end, while still on the original template, byfirst removing the ddpppN with the 3' editing-exonuclease activity ofDNA polymerase I in the absence of the one particular base at the end.Note that this accomplishes two things for the price of one. Not onlydoes it generate a ladder with a ligatable, end, because one canpre-determine the identity of the base removed, it provides anadditional nucleotide of DNA sequence information. One can use singlecolor detection in four separate reactions, or ultimately, four colordetection by mixing the results of four separate reactions prior tohybridization. If this approach is successful, it is amenable to moreelaborate variations combining laddering and hybridization. Note thateach of these procedures combines some of the power of ladder sequencingwith the parallel processing of SBH.

In addition, there are alternative methods of preparing the desiredsamples, such as polymerization in the absence of limiting amounts ofone of the substrate bases, such as for DNA, one of the four dNTPs.Standard Sanger or Maxam-Gilbert sequencing protocols cannot be used togenerate the ladder of DNA fragments because these techniques fail toyield 3'-ligatable ends. In contrast, sequencing by the method of thepresent invention combines the techniques and advantages of the power ofladder sequencing with the parallel processing power of positionalsequencing by hybridization.

Ligation ensures the fidelity of detection of the 3' terminal base ofthe target DNA. To ensure similar fidelity of detection at the 5' end ofthe duplex formed between the probe and the target, the probe-targetduplex can be extended after ligation by one nucleotide using, forexample, a labeled ddNTP (FIG. 5). This has two major advantages. First,specificity is increased because extension with the Klenow fragment ofDNA polymerase requires a correctly base paired 3'-primer terminus.Second, using labeled ddNTPs one at a time, or a mixture of all fourlabeled with four different colors simultaneously, the identity of oneadditional nucleotide of the target nucleic acid can be determined asshown in FIG. 5. Thus, an array of only 1024 probes would actually havethe sequencing power of an array of 4096 hexamers, in other words, acorresponding four-fold gain for any length used. In addition,polymerases work well in solid state sequencing methodologies quiteanalogous of the type proposed herein.

Example 7

Retaining positional information in sequencing by hybridization.Inherent in the detection of just the 3'-terminal sequence of the targetnucleic acid, is the possibility of obtaining information about thedistance between the sequence hybridized and a known reference point.Although that point could be arbitrary, the 5'-end of the intact targetwas used. The desired distance is then just the length of the DNAfragment that has hybridized to a particular probe in the array. Inprinciple, there are two ways to determine this length. One is to lengthfractionate (5' labeled) DNA before or after the hybridization,ligation, and any DNA polymerase extension. Single DNA sequences couldbe used, but pools of many DNA targets used simultaneously or,alternatively, a double-labeled target with one color representing the5'-end of any unique site and the other a random internal label would bemore efficient. For example, incorporated into the target is afractional amount, for example, about 1%, of biotinylated (ordigoxigenin-labeled) pyrimidines, and use this later on for fluorescentdetection. It has been recently shown that an internal label iseffective in high sensitivity conventional ladder DNA sequencing. Theratio of the internal label to the end label is proportional to targetfragment length. For any particular sample the relationship is monotoniceven though it may be irregular. Thus, correct order is always obtainedeven if distances are occasionally distorted by extreme runs of purinesof pyrimidines. If necessary, it is also possible to use twoquasi-independent internal labeling schemes.

The scheme as just outlined, used with polymerase extension, mightrequire as many as 6 different colored labels; 2 on the target (5' andinternal) and four on the probe extension (four ddNTPs). However the 5'label is unnecessary, since the 3' extension provides the sameinformation (providing that the DNA polymerase reaction is close tostoichiometric). The ddNTPs can be used one at a time if necessary.Therefore, the scheme could proceed with as little as two colordetection, if necessary (FIG. 7), and three colors would certainlysuffice.

A scheme complimentary to that shown in FIG. 7 would retain positionalinformation while reading the 5'-terminal sequence of 3'-end labeledplus internally labeled target nucleic acids. Here, as in FIG. 3B, probearrays with 5' overhangs are used, however, polymerase extension willnot be possible.

Example 8

Resolution of branch point ambiguities. In current SBH, branch pointambiguities caused by sequence recurrences effectively limit the size ofthe target DNA to a few hundred base pairs. The positional informationdescribed in Section 6 will resolve many of these ambiguities. When asequence recurrence occurs, if a complete DNA ladder is used as thesample, two or more targets will hybridize to the same probe. Singlenucleotide additions will be informative in 3/4 of the cases where twotargets are ligated to the same probe; they will reveal that a givenprobe contains two different targets and will indicate the sequence ofone base outside the recurrence. The easiest way to position the tworecurrent sequences is to eliminate the longer or shorter members of theDNA ladder and hybridize remaining species to the probe array. This is asufficiently powerful approach that it is likely to be a routine featureof positional SBH. Recurrences will be very frequent with only 5 or 6base overhangs, but the use of segmented ladders will allow most ofthese to be resolved in a straightforward way. It should not benecessary to physically fractionate the DNA species of the ladder(although this could certainly be done if needed). Instead, one can cutan end-labeled ladder with a restriction nuclease. For an effectivestrategy seven 4-base specific enzymes should be used, singly or incombination.

Additional information is available for the recurrence ofpentanucleotide sequences by the use of polymerase and single baseextension as described in Example 7. In three cases out of four thesingle additional base will be different for the two recurrentsequences. Thus, it will be clear that a recurrence has occurred.

The real power of the positional information comes, not from itsapplication to the recurrent sequences, but to its applications tosurrounding unique sequences. Their order will be determinedunequivocally, assuming even moderately accurate position information,and thus, the effect of the branch point will be eliminated. Forexample, 10% accuracy in intensity rations for a dual labeled 200 basepair target will provide a positional accuracy of 20 base pair. Thiswould presumably be sufficient to resolve all but the most extraordinaryrecurrences.

Branch point ambiguities are caused by sequence recurrence andeffectively limit the size of the target nucleic acid to a few hundredbase pairs. However, positional information derived from Example 7 willresolve almost all of these ambiguities. If a sequence recurs, more thanone target fragment will hybridize to, or otherwise be detected bysubsequent ligation to or extension from a single immobilized probe. Theapparent position of the target will be its average on the recurrentsequence. For a sequence which occurs just twice, the true location issymmetric around the apparent one. For example, the apparent position ofa recurrent sequence occurring in positions 50 and 100 bases from the5'-end of the target will be 75 bases from the end. However, when thepattern of positional sequencing by hybridization is examined, asequence putatively located at that position will show overlap withcontacts in the neighborhood of 50 bases and 100 bases from the 5'-end.This will indicate that a repeat has occurred.

Example 9

Extending the 3'-sequence of the target. Using the scheme shown in FIG.8, it is possible to learn the identity of the base 3' to the knownsequence of the target, as revealed by its hybridization position on anoligonucleotide array. For example, an array of 4^(n) single-strandedoverhangs of the type NAGCTA 3', as shown in the Figure, are createdwherein n is the number of known bases in an overhang of length n+1. Thetarget is prepared by using a 5' label in the manner shown in FIG. 3.The Klenow fragment of DNA polymerase would then be used to add a singledpppNp as a polymerization chain terminator (or alternatively, ddpppNterminators plus ligatable ends). Before hybridization the resulting3'-terminal phosphate would be removed by alkaline phosphatase. Thiswould allow subsequent ligation of the target to the probe array. Eitherby four successive single color 5' labels, or a mixture of fourdifferent colored chains, each color corresponding to a particular chainterminator, one would be able to infer the identity of the base that hadpaired with the N next to the sequence AGCTA. Labeling of the 5' endminimizes interference of fluorescent base derivatives on the ligationstep. Presumably, provided with a supply of dpppNp, or ribo-pppNp whichcan be easily prepared, the sequenase version 2 or another knownpolymerase will use these as a substrate. The key step in this scheme isto add a single dpppNp as a polymerization chain terminator. Beforehybridization, the resulting 3' terminal phosphate is removed byalkaline phosphatase. This allows for the subsequent ligation of thetarget to the probe array. Alternatively, ddpppNp terminators replacedwith ligatable ends may also be used. Either by four successive singlecolor 5' labels, or a mixture of four different colored chains, eachcolor representing a specific chain terminator, one is able to infer theidentity of the base that had paired with the N next to the sequenceAGCTA. The 5' end is labeled to minimize interference offluorescent-based derivatives with the ligation step.

Assuming that there are sufficient colors in a polychromatic detectionscheme, this 3' target extension can be combined with the 3' probeextension to read n+2 bases in an array of complexity 4^(n). This ispotentially quite a substantial improvement. It decreases the size ofthe array needed by a factor of 16 without any loss in sequencing power.However, the number of colors required begins to become somewhatdaunting. In principle one would want at least nine, four for each 3'extension and one general internal label for target length. However,with resonance ionization spectroscopy (RIS) detection, eight colors areavailable with just a single type of metal atom, and many more could behad with just two metals.

Example 10

Extending the 5' sequence of the target. In example 5, it wasillustrated that by polymerase extension of the 3'-end of the probe, asingle additional nucleotide on the target could be determined afterligation. That procedure used only chain terminators. Florescent labeleddNTPs that serve as substrates for DNA polymerase and other enzymes ofDNA metabolism can also be made. The probe-target complex of eachligation reaction with, for example, three labeled dNTPs and a fourthunlabeled chain terminator could be extended using fluorescent labeleddNTPs. This could be repeated, successively, with each possible chainterminator. If the ratio of the intensities of the different labels canbe measured fairly accurately, a considerable amount of additionalsequence information will be obtained. If the absolute intensities couldbe measured, the power of the method appears to be very substantialsince one is in essence doing a bit of four color DNA sequencing at eachsite on the oligonucleotide array. For example, as shown in FIG. 9, forthe sequence (Pu)₄ T, such an approach would unambiguously reveal 12 outof the 16 possible sequences and the remainder would be divided into twoambiguous pairs each. Alternatively, once the probe array has capturedtarget DNAs, full plus-minus DNA sequencing reactions could be carriedout on all targets. Single nucleotide DNA addition methods have beendescribed that would also be suitable for such a highly parallelizedimplementation.

Example 11

Sample pooling in positional sequencing by hybridization. A typical 200base pair target will detect only 196 probes on a five base 1024 probearray. This is not far from the ideal case in single, monochromaticsampling where one might like to detect half the probes each time.However, as the procedure is not restricted to single colors, the arrayis not necessarily this small. With an octanucleotide array, inconventional positional sequencing by hybridization or one of its hereindescribed enhancements, the target detects only 1/32 of the immobilizedprobes. To increase efficiency a mixture of 16 targets can be used withtwo enhancements. First, intelligently constructed orthogonal pools ofprobes can be used for mapping by hybridization. Hybridizationsequencing with these pools would be straightforward. Pools of targets,pools of probes, or pools of both can be used.

Second, in the analysis by conventional sequencing by hybridization ofan array of 2×10⁴ probes, divided into as few as 24 pools containing8×10³ probes each, there is a great deal of redundancy. Excluding branchpoints, 24 hybridizations could determine all the nucleic acid sequencesof all the targets. However, using RIS detection there are much morethan 24 colors. Therefore, all the hybridizations plus appropriatecontrols could be done simultaneously, provided that the density of thenucleic acid sample were high enough to keep target concentration far inexcess of all the probes. A single hybridization experiment couldproduce 4×10⁶ base pairs of sequence information. An efficientlaboratory could perform 25 such hybridizations in a day, resulting in athroughput of 10⁸ base-pairs of sequence per day. This is comparable tothe speed of polymerization by E. coli DNA polymerase.

Example 12

Oligonucleotide ligation after target hybridization. Stackinghybridization without ligation has been demonstrated in a simple format.Eight-mer oligonucleotides were annealed to a target and then annealedto an adjacent 5-mer to extend the readable sequence from 8 to 13 bases.This is done with small pools of 5-mers specifically chosen to resolveambiguities in sequence data that has already been determined byordinary sequencing by hybridization using 8-mers alone. The methodappears to work quite well, but it is cumbersome because a custom poolof 5-mers must be created to deal with each particular situation. Incontrast, the approach taken herein (FIG. 9), after ligation of thetarget to the probe, is to ligate a mixtures of 5-mers arranged inpolychromatically labeled orthogonal pools. For example, using 5-mers ofthe form pATGCAp or pATGCddA, only a single ligation event will occurwith each probe-target complex. These would be 3' labeled to avoidinterference with the ligase. Only ten pools are required for a binarysieve analysis of 5-mers. In reality it would make sense to use manymore, say 16, to introduce redundancy. If only four colors areavailable, those would require four successive hybridizations. Forexample, sixteen colors would allow a single hybridization. But theresult of this scheme is that one reads ten bases per site in the array,equivalent to the use of 4¹⁰ probes, but one only has to make 2×4⁵probes. The gain in efficiency in this scheme is a factor of 500 overconventional sequencing by hybridization.

Example 13

Synthesis of custom arrays of probes. Custom arrays of probe would beuseful to detect a change in nucleic acid sequence, such as any singlebase change in a pre-selected large population of sequences. This isimportant for detecting mutations, for comparative sequencing, and forfinding new, potentially rare polymorphisms. One set of target sequencescan be customized to an initial general array of nucleic acid probes toturn the probe into a specific detector for any alterations of aparticular sequence or series of sequences. The initial experiment isthe same as outlined above in Example 4, except that the 3'-blocked5-mers are unlabeled. After the ligation, the initial nucleic acidtarget strand along with its attached 18 nucleotide stalk is removed,and a new unligated 18 nucleotide stalk annealed to each element of theimmobilized array (FIG. 11). The difference is that because of itshistory, many (ideally 50% or more), of the elements of that array nowhave 10 base 3' extensions instead of 5 base extensions. These do notrepresent all 4¹⁰ possible 10-mers, but instead represent just those10-mers which were present in the original sample. A comparison samplecan now be hybridized to the new array under conditions that detectsingle mismatches in a decanucleotide duplex. Any samples which fail tohybridize are suspects for altered bases.

A problem in large scale diagnostic DNA sequencing is handling largenumbers of samples from patients. Using the approach just outlined, athird or a fourth cycle of oligonucleotide ligation could beaccomplished creating an array of 20-mers specific for the targetsample. Such arrays would be capable of picking up unique segments ofgenomic DNA in a sequence specific fashion and detecting any differencesin them in sample comparisons. Each array could be custom designed forone individual, without any DNA sequence determination and without anynew oligonucleotide synthesis. Any subsequent changes in thatindividual's DNA such as caused by oncogenesis or environmental insult,might be easily detectable.

Example 14

Positional sequencing by hybridization. Hybridization was performedusing probes with five and six base pair overhangs, including a fivebase pair match, a five base pair mismatch, a six base pair match, and asix base pair mismatch. These sequences are depicted in Table 5.

                  TABLE 5                                                         ______________________________________                                        Test Sequences:                                                               ______________________________________                                        5 bp overlap, perfect match:                                                  5'-TCG AGA ACC TTG GCT*-3'                                                                              (SEQ ID NO 1)                                       3'-CTA CTA GGC TGC GTA GTC                                                                              (SEQ ID NO 2)                                       5'-biotin-GAT GAT CCG ACG CAT CAG AGC TC-3'                                                             (SEQ ID NO 3)                                       5 bp overlap, mismatch at 3' end:                                             5'-TCG AGA ACC TTG GCT*-3'                                                                              (SEQ ID NO 1)                                       3'-CTA CTA GGC TGC GTA GTC                                                                              (SEQ ID NO 2)                                       5'-biotin-GAT GAT CCG ACG CAT CAG AGC TT-3'                                                             (SEQ ID NO 4)                                       6 bp overlap, perferct match:                                                 5'-TCG AGA ACC TTG GCT*-3'                                                                              (SEQ ID NO 1)                                       3'-CTA CTA GGC TGC GTA GTC                                                                              (SEQ ID NO 2)                                       5'-biotin-GAT GAT CCG ACG CAT CAG AGC TCT-3'                                                            (SEQ ID NO                                                                    13)                                                 6 bp overlap, mismatch four bases from 3' end:                                5'-TCG AGA ACC TTG GCT*-3'                                                                              (SEQ ID NO 1)                                       3'-CTA CTA GGC TGC GTA GTC                                                                              (SEQ ID NO 2)                                       5'-biotin-GAT GAT CCG ACG CAT CAG AGT TCT-3'                                                            (SEQ ID NO                                                                    14)                                                 ______________________________________                                    

The biotinylated double-stranded probe was prepared in TE buffer byannealing the complimentary single strands together at 68° C. for fiveminutes followed by slow cooling to room temperature. A five-fold excessof monodisperse, polystyrene-coated magnetic beads (Dynal) coated withstreptavidin was added to the double-stranded probe, which as thenincubated with agitation at room temperature for 30 minutes. Afterligation, the samples were subjected to two cold (4° C.) washes followedby one hot (90° C.) wash in TE buffer (FIG. 12). The ratio of ³² P inthe hot supernatant to the total amount of ³² P was determined (FIG.13). At high NaCl concentrations, mismatched target sequences wereeither not annealed or were removed in the cold washes. Under the sameconditions, the matched target sequences were annealed and ligated tothe probe. The final hot wash removed the non-biotinylated probeoligonucleotide. This oligonucleotide contained the labeled target ifthe target had been ligated to the probe.

Example 15

Compensating for variations in base composition. A major problem in allsuggested implementations of SBH is the rather marked dependence ofT_(m) on base composition, and, at least in some cases, on basesequence. The use of unusual salts like tetramethyl ammonium halides orbetaines (W. A. Rees et al., Biochemistry 32:137-44, 1993) offers oneapproach to minimizing these varieties. Alternatively, base analogs like2,6-diamino purine and 5-bromo U can be used instead of A and T,respectively to increase the stability of A-T base paris, andderivatives like 7-deazaG can be used to decrease the stability of G-Cbase pairs. The initial experiments shown in Table 2 indicate that theuse of enzymes will eliminate many of the complications due to basesequences. This gives the approach a very significant advantage overnon-enzymatic methods which require different conditions for eachnucleic acid and are highly matched to GC content.

Another method to compensate for differences in stability is to vary thebase next to the stacking site. Experiments are performed to test therelative effects of all four bases in this position on overallhybridization discrimination and also on relative ligationdiscrimination. Base analogs such as dU (deoxyuridine) and 7-deazaG arealso tested as components of the target DNA to see if these can suppresseffects of secondary structure. Single-stranded binding proteins mayalso be helpful in this regard.

Example 16

Data measurement, processing and interpretation. Highly automatedmethods for raw data handling and generation of contiguous DNA sequencefrom the hybridization are required for analysis of the data. Twomethods of data acquisition have been used in prior SBH efforts, CCDcameras with fluorescent labels and image plate analyzers withradiolabeled samples. The latter method has the advantage that there isno problem with uniform sampling of the array. However it is effectivelylimited to only two color analysis of DNA samples, by the use of ³⁵ Sand ³² P, differentially imaged through copper foil. In contrast, whileCCD cameras are less well developed, the detection of many colors ispossible by the use of appropriate exciting sources and filters. Fourcolors are available with conventional fluorescent DNA sequencingprimers or terminators. More than four colors may be achievable ifinfra-red dyes are used. However, providing uniform excitation of thefluorescent array is not a trivial problem. Both detection schemes areused and the image plate analyzers are sure to work. The CCD cameraapproach will be necessary if some of the multicolor labeling schemesdescribed in the proposal are ever to be realized. Label will introducedinto targets by standard enzymatic methods, such as the use of 5'labeled PCR primers, for 5' labeling, internally alpha ³² P labeledtriphosphates or fluorescent-labeled base analogs for internal labeling,and similar compounds by filling in staggered DNA ends for 3' labeling.

Both the Molecular Dynamics image plate analyzer and the Photometricscooled CCD camera can deal with the same TIFF 8 bit data formate. Thus,software developed for either instrument can be used to handle datameasured on both instruments. This will save a great deal of unnecessaryduplication in data processing software. Sequence interpretationsoftware can be developed for reading sequencing chip data andassembling it into contiguous sequence are already underway in Moscow,at Argonne National Laboratory, and in the private sector. Such softwareis generally available in the interested user community. The most usefulexamples of this software can be customized to fit the particularlyspecial needs of this approach including polychromatic detection,incorporation of positional information, and pooling schemes. Specificsoftware developments for constructing and decoding the orthogonal poolsof samples that may ultimately be used are being developed because theseprocedures are also needed for enhanced physical mapping methods.

Example 17

Generation of master beads. The general procedure for the generation ofmaster beads is depicted in FIG. 14. Forty microliters of DynabeadsM-280 Streptavidin were washed twice with 80 μl of TE (beadconcentration of 5 mg/ml). Final concentration of beads was about 5-10pmoles of biotinylated oligo for 40 μg of beads in a total volume of 80μl. East test oligo, in the form 5'-biotin-N₁ N₂ N₃ N₄ N₅ -10 bp-3', wasdissolved in TE to a concentration of 10 pmol/40 μl (250 nM). Eightymicroliters of oligo were added and the mixture shaken gently for 15minutes in a vortex at low speed.

                  TABLE 6                                                         ______________________________________                                        Stock solutions of MPROBEN in 1 ml Th pH 7.5                                  MPROBEA    94 μg  12,200 pmol                                                                             20 μl in 1 ml                               MPROBEC   121 μg  15,800 pmol                                                                             16 μl in 1 ml                               MPROBEG    94 μg  12,300 pmol                                                                             20 μl in 1 ml                               MPROBET   147 μg  19,200 pmol                                                                             13 μl in 1 ml                               Stock solution of MCOMPBIO in 5 ml Th pH 7.5                                  MCOMPBIO      464,000 pmol                                                                             5 μl in 1.85 ml                                   ______________________________________                                    

Tubes were placed in the Dynal MPC apparatus and the supernatantremoved. Unbound streptavidin sites were sealed with 5 μl of 200 μM freebiotin in water. Wash the beads several times with 80 μl TE. These beadscan store in this state at 4° C. for several weeks.

250 nM of 5'-biotinylated 18 base nucleic acid (the complement of theconstant region) served as primer for enzymatic extension of the proberegion. The tube was heated to 68° C. and allowed to cool to roomtemperature. Beads were kept in suspension by tipping gently.Supernatant was removed and washed with 40 μl TE several times. The tubewas removed from the magnet and the beads resuspended in 40 μl of TE toremove excess complement. The bead suspension was equally divided among4 tubes and the stock tube washed with the wash divided among the tubesas well. Supernatant was removed and washed with water. Each tubecontained about 2-5 pmol of DNA (28-72 ng; see Table 6).

Polymerase I extension was performed on each tube of DNA in a total of13 μl as follows (see Table 7): NEB buffer concentration was 10 mMTris-HCl, pH 7.5, 5 mM MgCl₂, 7.5 mM DTT; 33 μM d(N-N_(i))TP mix; 2μM+³² P dN_(i) TP complimentary to one of the N_(i) bases; andpolymerase I large fragment (klenow). In the first well was added dTTP,dCTP and dGTP, to a concentration of 33 μM. ³² P-dATP was added to aconcentration of 3 μM. dNTP stock solutions of 200 μM were pooled tolack the labelled nucleotide (i.e. Tube A contains C,G and T) adding 6.3μl dNTP, 5 μl 200 μM dNTP, and 43 μl water. Radioactively labeled(*dNTP) stock solutions were 20 μM prepared from 2 μl α³² P! dNTP, 5 μl200 μM dNTP, and 43 μl water.

                  TABLE 7                                                         ______________________________________                                        TUBE #     A            C         G        T                                  ______________________________________                                        10 × buffer                                                                        1.3   μl  1.3 μl 1.3 μl                                                                              1.3 μl                          dATP       1.5   μl* 2.1 μl 2.1 μl                                                                              2.1 μ1                          dCTP       2.1   μl  1.5 μl*                                                                              2.1 μl                                                                              2.1 μl                          dGTP       2.1   μl  2.1 μl 1.5 μl*                                                                             2.1 μl                          dTTP       2.1   μl  2.1 μl 2.1 μl                                                                              1.5 μl*                         Enzyme     1     μl  1   μl 1   μl                                                                              1   μl                          of stock   5U           5U        5U       5U                                 H.sub.2 O  1.9   μl  1.9 μl 1.9 μl                                                                              1.9 μl                          ______________________________________                                    

The tubes were incubated at 25° C. for 15 minutes. To optimize theyields of enzymatic extension, higher concentrations of dNTPs and longerreaction time may be required. The reaction was stopped by adding 4 μlof 50 mM EDTA to a final concentration of 11 μM. The supernatant wasremoved and the beads rinsed with 40 μl of TE buffer several times andresuspended in 35 μl of TE. The whole tube was counted and it wasexpected that there would be about 8% incorporation of the label added.

As a test of the synthesized oligo transfer, magnetic beads weresuspended in 50 μl of 0.1M NaOH and incubated at room temperature for 10minutes. The supernatant from each tube was removed and transfer tofresh tube. Beads were incubated a second time with 50 μl of 0.1M NaOH.As many counts seemed to remain, the first set of beads were heated to68° C. in 50 μl NaOH which leached out a lot more counts. Each base wasneutralized with 1M HCl followed by 50 μl of TE. Fresh Dynabeads wereadded to the melted strand and incubated at room temp for 15 minuteswith gentle shaking. Supernatants were removed and saved for counting.The beads were washed several times with TE. Results are shown in Table8.

                  TABLE 8                                                         ______________________________________                                        Incorporation of label (MPROBEC 5'-CATGG---)                                  ______________________________________                                               A   28,711/779,480                                                            C   35,193/574,760                                                            G   15,335/754,400                                                            T   43,048/799,440                                                     ______________________________________                                               Transferred                                                                             Non bound   Unmelted                                                                             Efficiency                                ______________________________________                                        A       9,812    2,330       10,419 43.4%                                     C      13,158    3,950       8,494  51.4%                                     G       5,621    2,672       1,924  55.0%                                     T      15,898    5,287       5,942  58.6%                                     ______________________________________                                    

Transferred refers to synthesized strand captured on fresh beads.Unbound refers to the synthesized strand that was not captured by thebead and unmelted refers to counts remaining on the original beads. Ascan be observed, between about 43% and 58% of the newly synthesizedstrands were successfully transferred indicating that an array of suchstrands could be successfully replicated.

Example 18

A procedure for making complex arrays by PCR. A slightly complex, butconsiderably improved scheme to test the generality of the new approachto SBH, without the need to synthesize, seprately, all 1024 five-merprobes has been developed. This procedure allows one to generate arrayswith 5'- and/or 3'-overhangs and uses PCR to prepare the final probesused for hybridization which may easily be labeled with biotin. It alsobuilds in a way of learning part or even all of the identity of eachprobe sequence.

Chemical synthesis was used to make the following sequences:

(a) 5'-GTCGACAGTTGACGCTACCAYNNNNRTGGTCTAGAGCTAGC-3' (SEQ ID NO 15)

(b) 5'-CTCGAGAGTTGACGCTACCARNNNNYTGGTCTAGACCCGGG-3' (SEQ ID NO 16)

Next, enzymatic extension of the apropriate primers using a DNApolymerase in the presence of high concentrations of dNTPs was used tomake the complementary duplexes. In the above sequences, N represents anequimolar mixture of all 4 bases; R is an equimolar mixture of A and G;and Y is an equimolar mixture of T and C. The underlined sequences areBst XI and Hga I recognition sites. ##STR1##

The seqences were designed with these internal Bst XI-cutting site whichallows for the generation of complementary, 4 base 3'-overhangingsingle-strands which can be coverted to 5 base 3'-overhangs (see below)used for the type of positional SBH shown in FIG. 2A. ##STR2##

The Hga I-cutting site overlaps with the Bst XI-cutting site and allowsfor the generation of 5 base 5'-overhanging single-strands. This is thestructure needed for the type of postional SBH shown in FIG. 2B, and canalso be used for subsequent sequencing of the overhangs by primerextension. ##STR3##

The 5'- and 3'-terminal sequences of strand (a) are also recognitionsites for Sal I and Nhe I, respectively; the corresponding sequence instrand (b) are recognition sites for Xho I and Xma I, respectively:

    ______________________________________                                        5'-GTCGAC-3'  Sal I     5'-G  TCGAC-3'                                        3'-CAGCTG-5'  →  3'-CAGCT  G-5'                                        5'-GCTAGC-3'  Nbe I     5'-G  CTAGC-3'                                        3'-CGATCG-5'  →  3'-CGATC  G-5'                                        5'-CTCGAG-3'  Xho I     5'-C  TCGAG-3'                                        3'-GAGCTC-5'  →  3'-GAGCT  C-5'                                        5'-CCCGGG-3'  Xma I       5'-C CCGGG-3'                                       3'-GGGCCC-5'  →  3'-GGGCC  C-5'                                        ______________________________________                                    

Those cloning sites are chosen such that, even with the degeneracyallowed by the sequences 5'-YNNNNR-3' and 5'-RNNNNY-3', these enzymeswill not cleave the probe regions. For cloning, duplexes (a) werecleaved with both Sal I and Nhe I restriction enzymes (or duplexes (b)with Xho I and Xma I. The resulting digestion products weredirectionally cloned into an appropriate vector (e.g., plasmid, phage,etc.), suitable cells were transforned with the vector, and coloniesplated. Individual clones were picked and their DNA amplified by PCRusing vector sequences downstream and upstream from the cloned sequencesas the primers. This was done to increase the length of the PCR productsto ease the manipulation of these products. The probe regions fromindividual clones were amplified by PCR with one biotinylated primercorresponding to the 5'-bases of the bottom strand. In a separate PCR,the lcoations of the biotins were reversed. The resulting PCR productsin each case were cleaved with Bst XI, and the biotin-labeled productscaptured on streptavindin beads or surfaces. Note that by using PCRamplification instead of DNA purification, the need to separately purifyand biotinylate each clone is also eliminated.

In parallel, all the PCR products were cleaved by Hga I which generates5'-overhangs consisting of randomized sequences. The identity of eachclone can then be determined by separate primer extensions of each ofthe two DNA pieces resulting from Hga I cleavage. For each pair ofsequences, which derive from the same clone, the overhangs must becomplementary. Therefore, sequencing just three bases on each fragmentstrand will given the entire structure of two probes. This plus/minussequencing can be done in microtire plates and is easily automated. Itwill fail only in the few cases were 5'-RNNNNY-3' in strand (b) contains5'-GACGC-3', which is the recognition site for Hga I. The number ofprier extension reactions required can be reduced by synthesis of morerestricted pools of sequences. For example, using 4 pools where the basein one particular postion is known in advance, such as 5'-YNNANR-3'.

To make the probes needed for positional SBH (as sown in FIG. 2A), theduplex PCR products are first attached to a solid support throughstreptavidin. They are then cleaved with Bst XI to generate thefollowing pairs of products:

5'-B-GTCGACAGTTGACGCTACCAYNNNN-3' (SEQ ID NO 25)

3'-CAGCTGTCAACTGCGATGGTR-5' (SEQ ID NO 26)

5'-B-GCTAGCTCTAGACCAYNNNN-3' (SEQ ID NO 27)

3'-CGATCGAGATCTGGTR-5' (SEQ ID NO 28)

5'-B-CTCGAGAGTTGACGCTACCARNNNN-3' (SEQ ID NO 29)

3'-GAGCTCTCAACTGCGATGGTY-5' (SEQ ID NO 30)

5'-B-CCCGGGTCTAGACCARNNNN-3' (SEQ ID NO 31)

3'-GGGCCCAGATCTGGTY-5' (SEQ ID NO 32)

The 5 base 3' overhangs needed for positional SBH are made by replacingthe complementary (non-biotinylated) strands with constant strands whichare one base shorter.

5'-B-GTCGACAGTTGACGCTACCAYNNNN-3' (SEQ ID NO 25)

3'-CAGCTGTCAACTGCGATGGT-5' (SEQ ID NO 33)

5'-B-GCTAGCTCTAGACCAYNNNN-3' (SEQ ID NO 27)

3'-CGATCGAGATCTGGT-5' (SEQ ID NO 34)

5'-B-CTCGAGAGTTGACGCTACCARNNNN-3' (SEQ ID NO 29)

3'-GAGCTCTCAACTGCGATGGT-5' (SEQ ID NO 35)

5'-B-CCCGGGTCTAGACCARNNNN-3' (SEQ ID NO 31)

3'-GGGCCCAGATCTGGT-5' (SEQ ID NO 36)

This generates the 5 base 3'-overhanging arrays amenable to extensionwith Sequenase version 2.0 after the ligation step shown in FIGS. 2A andB. Randomly chosen arrays of 5,120 (5× coverage) are needed to ensurethat all of the sequences (>99%) are present, but this array is muchlarger than optimal. In practice, a library will need only provideapproximately 63% of the sequences and, if necessary, can besupplemented to fill in the missing variable clones by direct synthesis.

Other embodiments and uses of the invention will be apparent to thoseskilled in the art from consideration of the specification and practiceof the invention disclosed herein. It is intended that the specificationand examples be considered exemplary only, with the true scope andspirit of the invention being indicated by the following claims.

    __________________________________________________________________________    SEQUENCE LISTING                                                              (1) GENERAL INFORMATION:                                                      (iii) NUMBER OF SEQUENCES: 48                                                 (2) INFORMATION FOR SEQ ID NO:1:                                              (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 15 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:                                       TCGGTTCCAAGAGCT15                                                             (2) INFORMATION FOR SEQ ID NO:2:                                              (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 18 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:                                       CTGATGCGTCGGATCATC18                                                          (2) INFORMATION FOR SEQ ID NO:3:                                              (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 23 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:                                       GATGATCCGACGCATCAGAGCTC23                                                     (2) INFORMATION FOR SEQ ID NO:4:                                              (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 23 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:                                       GATGATCCGACGCATCAGAGCTT23                                                     (2) INFORMATION FOR SEQ ID NO:5:                                              (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 23 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:                                       GATGATCCGACGCATCAGAGCTA23                                                     (2) INFORMATION FOR SEQ ID NO:6:                                              (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 23 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:                                       GATGATCCGACGCATCAGAGCCC23                                                     (2) INFORMATION FOR SEQ ID NO:7:                                              (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 23 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:                                       GATGATCCGACGCATCAGAGTTC23                                                     (2) INFORMATION FOR SEQ ID NO:8:                                              (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 23 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:                                       GATGATCCGACGCATCAGAACTC23                                                     (2) INFORMATION FOR SEQ ID NO:9:                                              (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 23 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:                                       GATGATCCGACGCATCAGAGATC23                                                     (2) INFORMATION FOR SEQ ID NO:10:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 23 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:                                      GATGATCCGACGCATCAGAGCTT23                                                     (2) INFORMATION FOR SEQ ID NO:11:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 23 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:                                      GATGATCCGACGCATCAGATATC23                                                     (2) INFORMATION FOR SEQ ID NO:12:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 23 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:                                      GATGATCCGACGCATCAGATATT23                                                     (2) INFORMATION FOR SEQ ID NO:13:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 24 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13:                                      GATGATCCGACGCATCAGAGCTCT24                                                    (2) INFORMATION FOR SEQ ID NO:14:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 24 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14:                                      GATGATCCGACGCATCAGAGTTCT24                                                    (2) INFORMATION FOR SEQ ID NO:15:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 41 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15:                                      GTCGACAGTTGACGCTACCAYNNNNRTGGTCTAGAGCTAGC41                                   (2) INFORMATION FOR SEQ ID NO:16:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 41 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16:                                      CTCGAGAGTTGACGCTACCARNNNNYTGGTCTAGACCCGGG41                                   (2) INFORMATION FOR SEQ ID NO:17:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 12 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:17:                                      GCTAGCTCTAGA12                                                                (2) INFORMATION FOR SEQ ID NO:18:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 41 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:18:                                      GCTAGCTCTAGACCAYNNNNRTGGTAGCGTCAACTGTCGAC41                                   (2) INFORMATION FOR SEQ ID NO:19:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 12 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19:                                      CCCGGGTCTAGA12                                                                (2) INFORMATION FOR SEQ ID NO:20:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 41 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20:                                      CCCGGGTCTAGACCARNNNNYTGGTAGCGTCAACTCTCGAG41                                   (2) INFORMATION FOR SEQ ID NO:21:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 12 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21:                                      CCANNNNNNTGG12                                                                (2) INFORMATION FOR SEQ ID NO:22:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 12 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:22:                                      CCANNNNNNTGG12                                                                (2) INFORMATION FOR SEQ ID NO:23:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 15 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23:                                      GACGCNNNNNNNNNN15                                                             (2) INFORMATION FOR SEQ ID NO:24:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 15 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24:                                      NNNNNNNNNNGCGTC15                                                             (2) INFORMATION FOR SEQ ID NO:25:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 25 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25:                                      GTCGACAGTTGACGCTACCAYNNNN25                                                   (2) INFORMATION FOR SEQ ID NO:26:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 21 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26:                                      RTGGTAGCGTCAACTGTCGAC21                                                       (2) INFORMATION FOR SEQ ID NO:27:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 20 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:27:                                      GCTAGCTCTAGACCAYNNNN20                                                        (2) INFORMATION FOR SEQ ID NO:28:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 16 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:28:                                      RTGGTCTAGAGCTAGC16                                                            (2) INFORMATION FOR SEQ ID NO:29:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 25 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:29:                                      CTCGAGAGTTGACGCTACCARNNNN25                                                   (2) INFORMATION FOR SEQ ID NO:30:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 21 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:30:                                      YTGGTAGCGTCAACTCTCGAG21                                                       (2) INFORMATION FOR SEQ ID NO:31:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 20 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:31:                                      CCCGGGTCTAGACCARNNNN20                                                        (2) INFORMATION FOR SEQ ID NO:32:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 16 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:32:                                      YTGGTCTAGACCCGGG16                                                            (2) INFORMATION FOR SEQ ID NO:33:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 20 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:33:                                      TGGTAGCGTCAACTGTCGAC20                                                        (2) INFORMATION FOR SEQ ID NO:34:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 15 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:34:                                      TGGTCTAGAGCTAGC15                                                             (2) INFORMATION FOR SEQ ID NO:35:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 20 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:35:                                      TGGTAGCGTCAACTCTCGAG20                                                        (2) INFORMATION FOR SEQ ID NO:36:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 15 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:36:                                      TGGTCTAGACCCGGG15                                                             (2) INFORMATION FOR SEQ ID NO:37:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 13 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:37:                                      GCAGCNNNNNNNN13                                                               (2) INFORMATION FOR SEQ ID NO:38:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 17 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:38:                                      NNNNNNNNNNNNGCTGC17                                                           (2) INFORMATION FOR SEQ ID NO:39:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 11 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:39:                                      GCCNNNNNGGC11                                                                 (2) INFORMATION FOR SEQ ID NO:40:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 12 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:40:                                      CCANNNNNNTGG12                                                                (2) INFORMATION FOR SEQ ID NO:41:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 14 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:41:                                      GGATGNNNNNNNNN14                                                              (2) INFORMATION FOR SEQ ID NO:42:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 18 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:42:                                      NNNNNNNNNNNNNCATCC18                                                          (2) INFORMATION FOR SEQ ID NO:43:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 10 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:43:                                      GACGCNNNNN10                                                                  (2) INFORMATION FOR SEQ ID NO:44:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 15 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:44:                                      NNNNNNNNNNGCGTC15                                                             (2) INFORMATION FOR SEQ ID NO:45:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 11 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:45:                                      CCANNNNNTGG11                                                                 (2) INFORMATION FOR SEQ ID NO:46:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 10 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:46:                                      GCATCNNNNN10                                                                  (2) INFORMATION FOR SEQ ID NO:47:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 14 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:47:                                      NNNNNNNNNGATGC14                                                              (2) INFORMATION FOR SEQ ID NO:48:                                             (i) SEQUENCE CHARACTERISTICS:                                                 (A) LENGTH: 13 base pairs                                                     (B) TYPE: nucleic acid                                                        (C) STRANDEDNESS: single                                                      (D) TOPOLOGY: linear                                                          (xi) SEQUENCE DESCRIPTION: SEQ ID NO:48:                                      GGCCNNNNNGGCC13                                                               __________________________________________________________________________

We claim:
 1. A method for replicating an array of single-stranded probeson a solid support comprising the steps of:a) synthesizing an array ofnucleic acids each comprising a non-variant sequence of length C at a3'-terminus and a variable sequence of length R at a 5'-terminus; b)fixing the array to a first solid support; c) synthesizing a set ofnucleic acids each comprising a sequence complementary to thenon-variant sequence; d) hybridizing the nucleic acids of the set to thearray; e) enzymatically extending the nucleic acids of the set using thevariable sequences of the array as templates; f) denaturing the set ofextended nucleic acids; and g) fixing the denatured nucleic acids of theset to a second solid support to create the replicated array ofsingle-stranded probes.
 2. The method of claim 1 wherein the nucleicacids of the set are conjugated with biotin and the second solid supportcomprises streptavidin.
 3. The method of claim 1 wherein the nucleicacids of the array are between about 15-30 nucleotides in length and thenucleic acids of the set are between about 10-25 nucleotides in length.4. The method of claim 1 wherein C is between about 7-20 nucleotides andR is between about 3-5 nucleotides.
 5. The method of claim 1 wherein thesolid supports are selected from the group consisting of plastics,ceramics, metals, resins, gels, membranes and chips.
 6. The method ofclaim 1 wherein the nucleic acids of the set are enzymatically extendedwith a DNA polymerase and one or more deoxynucleotide triphosphates. 7.The method of claim 1 wherein denaturing is performed with heat, alkali,organic solvents, binding proteins, enzymes, salts or combinationsthereof.
 8. The method of claim 1 further comprising the step ofhybridizing the replicated array with a second set of nucleic acidscomplementary to the non-variant sequence of the replicated array tocreate a double-stranded replicated array.
 9. The method of claim 1wherein the solid supports are two-dimensional or three-dimensionalmatrixes.
 10. The method of claim 8 wherein a double-stranded portion ofthe partially double-stranded replicated array comprise a restrictionendonuclease site.
 11. The method of claim 8 wherein the partiallydouble-stranded replicated array have 5'- or 3'-overhangs.
 12. Themethod of claim 8 wherein the partially double-stranded replicated arraycomprises about 4^(R) different probes.
 13. The method of claim 8wherein the partially double-stranded replicated array comprise adetectable label.
 14. The method of claim 13 wherein the detectablelabel is selected from the group consisting of radioisotopes, stableisotopes, enzymes, fluorescent and luminescent chemicals, chromaticchemicals, metals, electric charges, and spatial chemicals.
 15. A methodfor replicating an array of single-stranded probes on a solid supportcomprising the steps of:a) fixing a first array of nucleic acids eachcomprising a non-variant sequence of length C at a 3'-terminus and avariable sequence of length R at a 5'-terminus to a first solid support;b) synthesizing a first set of nucleic acids each comprising a sequencecomplementary to the non-variant sequence; c) hybridizing the nucleicacids of the first set to the first array; d) enzymatically extendingthe nucleic acids of the first set using the variable sequences of thefirst array as templates; e) denaturing the first set of extendednucleic acids; f) fixing the denatured nucleic acids of the first set toa second solid support to create the replicated array of single-strandedprobes; and g) hybridizing the replicated array with a second set ofnucleic acids complementary to the constant sequence of the replicatedarray to create a partially double-stranded replicated array.
 16. Themethod of claim 15 wherein the nucleic acids of the first set areconjugated with biotin and the second solid support comprisesstreptavidin.
 17. The method of claim 15 wherein the nucleic acids ofthe first array are between about 15-30 nucleotides in length and thenucleic acids of the first set are between about 10-25 nucleotides inlength.
 18. The method of claim 15 wherein C is between about 7-20nucleotides and R is between about 3-5 nucleotides.
 19. The method ofclaim 15 wherein the partially double-stranded replicated arraycomprises about 4^(R) different probes.
 20. The method of claim 15wherein the solid supports are selected from the group consisting ofplastics, ceramics, metals, resins, gels, membranes and chips.
 21. Themethod of claim 15 wherein the solid supports are two-dimensional orthree-dimensional matrixes.
 22. A method for replicating an array ofsingle-stranded probes on a solid support comprising the steps of:a)fixing an array of nucleic acids each comprising a non-variant sequenceof length C at a 3'-terminus and a variable sequence of length R at a5'-terminus to a first solid support; b) synthesizing a set of nucleicacids each comprising a sequence complementary to the non-variantsequence; c) hybridizing the nucleic acids of the set to the array; d)enzymatically extending the nucleic acids of the set using the variablesequences of the array as templates; e) denaturing the set of extendednucleic acids; and f) fixing the denatured nucleic acids of the set to asecond solid support with a streptavidin-biotin or an avidin-biotin bondto create the replicated array of single-stranded probes.
 23. The methodof claim 22 wherein the nucleic acids of the array are between about15-30 nucleotides in length and the nucleic acids of the set are betweenabout 10-25 nucleotides in length.
 24. The method of claim 22 wherein Cis between about 7-20 nucleotides and R is between about 3-5nucleotides.
 25. The method of claim 22 wherein the solid supports areselected from the group consisting of plastics, ceramics, metals,resins, gels, membranes and chips.
 26. The method of claim 22 whereinthe nucleic acids of the set are enzymatically extended with a DNApolymerase and one or more deoxynucleotide triphosphates.
 27. The methodof claim 22 wherein denaturing is performed with heat, alkali, organicsolvents, binding proteins, enzymes, salts or combinations thereof. 28.The method of claim 22 wherein the solid supports are two-dimensional orthree-dimensional matrixes.
 29. The method of claim 22 wherein thereplicated array comprises about 4^(R) different probes.